ࡱ>  wypqrstuv{em%` "bjbjٕ 72x8$8$8$8$$$$%JJJ@@KL%iUNZ$r[r[[@fPk,m$}h$r*e indicates that the Enter key (or Return key on some keyboards) must be pressed. Example: Type Y for Yes or N for No and press indicates that the Tab key must be pressed. Example: Press to move the cursor to the next field.  Indicates especially important or helpful information.  Options are locked with a particular security key. The user must hold the particular security key to be able to perform the menu option. Example:  Without the PSXCOMPMGR key the Consolidated Mail Outpatient Pharmacy options cannot be accessed. ( The page symbol indicates a referral to a diagram. ?, ??, ??? One, two or three question marks can be entered at any of the prompts for online help. One question mark elicits a brief statement of what information is appropriate for the prompt. Two question marks provide more help, plus the hidden actions, and three question marks will provide more detailed help, including a list of possible answers, if appropriate. ^ Up arrow (caret or a circumflex) and pressing can be used to exit the present option. Technical Manual (This page included for two-sided copying.) Implementation and Maintenance The PHARMACY ORDERABLE ITEM file (#50.7) must be built prior to the installation of Outpatient Pharmacy V. 7.0 and Inpatient Medications V. 5.0. The PHARMACY ORDERABLE ITEM file (#50.7) will be similar to the PRIMARY DRUG file (#50.3) used by Inpatient Medications V. 4.5. The main difference is that each entry in the PHARMACY ORDERABLE ITEM file (#50.7) has an associated Dosage Form that will always print next to the name. The PHARMACY ORDERABLE ITEM file (#50.7) will be duplicated in the ORDERABLE ITEM file (#101.43) that will reside in CPRS V. 1.0. Any update to the PHARMACY ORDERABLE ITEM file (#50.7) will automatically update the corresponding entry in the ORDERABLE ITEM file (#101.43). The NAME field (#.01) and the DOSAGE FORM field (#.02) values in the PHARMACY ORDERABLE ITEM file (#50.7) will print on Outpatient Pharmacy reports, profiles, Inpatient Medication reports, MAR labels etc., in place of the Primary Drug Name. The PHARMACY ORDERABLE ITEM file (#50.7) includes the following fields. These fields reflect the package content up to and including the release of patch PSS*1*68. ( These fields were necessary for the initial installation but were deleted following later patches. * These fields were not exported with the initial installation but were added with later patches. Field Number Field NameDescription.01NAMEThis is the name of the Pharmacy Orderable Item. It is a free text field that can be up to 40 characters in length..02DOSAGE FORMThis is a pointer to the DOSAGE FORM file (#50.606). This is a required field and will always print next to the Pharmacy Orderable Item name..03IV FLAGThis field will be set to 1 to indicate that the Pharmacy Orderable Item entry is pointed to by either the IV ADDITIVES file (#52.6), or the IV SOLUTIONS file (#52.7). If this field is not set to 1, it indicates that the entry is pointed to from the DRUG file (#50)..04INACTIVE DATEThis will contain the date the entry had been made inactive..05DAY (nD) or DOSE (nL) LIMITThis is a free text field used to calculate a default value for the "STOP DATE" prompt of the order..06MED ROUTEThis is a pointer to the MEDICATION ROUTES file (#51.2). If a MED ROUTE is entered here, it will be used as the default value during order entry when this drug is selected..07SCHEDULE TYPEThis field is a set of codes and will be used as a default value when selecting this drug in order entry..08SCHEDULEThis is a free text field and will be used as a default value during order entry when this drug is selected..09SUPPLYThis is a set of codes with 1 (one) indicating that the Orderable Item is a supply.2SYNONYM (multiple)This multiple will contain all the associated synonyms for the Pharmacy Orderable Item. .01SYNONYMA free text synonym name up to 30 characters long.(3 CORRESPONDING UD ITEMIf CHANGE TYPE OF ORDER FROM OERR field (#20.412) in the PHARMACY SYSTEM file (#59.7) parameter in Inpatient Mediations package is set, this field will be asked to user. This field will indicate corresponding Orderable Items to choose from and which package (UD or IV) to finish the order.(4CORRESPONDING IV ITEMIf CHANGE TYPE OF ORDER FROM OERR field (#20.412) in the PHARMACY SYSTEM file (#59.7) parameter in Inpatient Mediations package is set, this field will be asked to user. This field will indicate corresponding Orderable Items to choose from and which package (UD or IV) to finish the order.  *5FORMULARY STATUSThis field will designate the formulary status of the Orderable Item. The non-formulary status will be displayed to the provider next to the selectable list of Orderable Item(s) during CPRS order entry (List Manager and GUI). This field is not editable. The software controls it. An Orderable Item will only be marked as non-formulary if there are no active Dispense Drugs that are formulary drugs matched to the item. *6OI-DRUG TEXT ENTRY (multiple)*.01OI-DRUG TEXT ENTRYThis is a pointer to the DRUG TEXT file (#51.7). This file contains such information as drug restrictions, guidelines and protocols to help assure that medications are being used according to formulary specifications. This information will be seen in CPRS and Pharmacy when a medication order is placed for the Pharmacy Orderable Item. New entries to the DRUG TEXT file (#51.7) must be made through the Drug Text Enter/Edit option. *7 PATIENT INSTRUCTIONSThe text in this field shall be presented as a default for the Patient Instructions prompt in the Outpatient Pharmacy package when entering orders, if the Dispense Drug selected is matched to this Pharmacy Orderable Item. This text will also be presented during the Outpatient Medication order entry process through CPRS, and the CPRS user can then determine whether or not these Instructions should be part of the order. For all words entered in this field, the software will check for expansions for each word in the MEDICATION INSTRUCTION file (#51) and expand the word accordingly. 7.1OTHER LANGUAGE INSTRUCTIONSThe text in this field shall be presented as a default for the OTHER PATIENT INSTRUCTIONS prompt in the Outpatient Pharmacy package when entering orders, if the order being entered is for a patient who has designated a preference for another language.8NON-VA MEDThis field indicates whether the Pharmacy Orderable Item is selectable as a Non-VA Med (either an herbal supplement, an over-the-counter (OTC) medication, or a prescription drug not dispensed by the VA). This field is not editable. Work Flowchart for Creating and Matching Orderable Items Below are the instructions for matching Orderable Items during the initial installation of PDM.   Steps 12 and 13 would be used to edit Orderable Items following the initial setup of PDM. Steps in Creating the Pharmacy Orderable Item File The following steps to create Orderable Items must be performed prior to installing any patches to the PDM package. Following the installation of patches, these steps may not be run. Instead, the user would access the Dispense Drug/ Orderable Item Maintenance option to create new Orderable Items. STEP 1 The first two options in the Pharmacy Data Management menu, (Primary/VA Generic Orderable Item Report and VA Generic Orderable Item Report), should be run first. These reports will reflect what the PHARMACY ORDERABLE ITEM file (#50.7) will look like, based on which of the two methods is chosen when creating the PHARMACY ORDERABLE ITEM file (#50.7) The Primary/VA Generic Orderable Item Report option will use your existing PRIMARY DRUG file (#50.3), as a basis of creating the new file. The VA Generic Orderable Item Report option will use the VA Generic name from the VA GENERIC file (#50.6), as a basis for creating the new file. There may be some instances of a drug not being matched when the report said it would be matched, but these instances should be limited to a very few. Various factors come into play with these two methods. If the PHARMACY ORDERABLE ITEM file (#50.7) is created by VA Generic Name, then the PRIMARY DRUG file (#50.3) must be a duplication of the DRUG file (#50). In either method, the more entries in the DRUG file (#50) that are matched to the VA GENERIC file (#50.6), the more Orderable Items the software can automatically create. If the file is created by Primary/VA Generic Name, once the Primary Name portion of the option is finished, the software will also create as many entries as it can based on the VA Generic name. One advantage of creating the PHARMACY ORDERABLE ITEM file (#50.7) by Primary Name is that all entries created via the PRIMARY DRUG file (#50.3) will have certain fields automatically populated, by being carried over from the PRIMARY DRUG file (#50.3) to the PHARMACY ORDERABLE ITEM file (#50.7). These fields are DAY (nD) or DOSE (nD), MED ROUTE, SCHEDULE TYPE, SCHEDULE, and the SYNONYM multiple. For either method, IV Additives and IV Solutions will also have entries created for them in the PHARMACY ORDERABLE ITEM file (#50.7). Three files will point to the PHARMACY ORDERABLE ITEM file (#50.7); they are the DRUG file (#50), the IV ADDITIVES file (#52.6), and the IV SOLUTIONS file (#52.7). STEP 2 The third option in the Pharmacy Data Management menu, Create Pharmacy Orderable Items, is the option that actually creates the entries in the PHARMACY ORDERABLE ITEM file (#50.7), and creates the pointers in the files mentioned in step 1. Based on the reports generated in step 1, the new file can be created by using either of the two methods. STEP 3 The Manually Match Dispense Drugs option should be run next. This option will step through all the remaining entries in the IV ADDITIVES file (#52.6), the IV SOLUTIONS file (#52.7), and the DRUG file (#50), and ask the user to match any unmatched drugs to an entry in the PHARMACY ORDERABLE ITEM file (#50.7). The user will be required to match all Additives and Solutions with valid pointers to the DRUG file (#50), and all entries in the DRUG file (#50) that are marked with an I, O, or U in the APPLICATION PACKAGES USE field (#63) which are active or have an active date of a year or less. Each time this option is run, upon exit of the option, a check will be done to see if there are any drugs that are still not matched that should be matched according to the rules mentioned above. If there are, a message will be given stating this and reminding the user that someone will have to return to this option and continue matching drugs until they are all matched. If upon exit, all the necessary drugs are matched, a message will be given, and a job will be queued to do a final check on the file for any invalid data. Upon completion of that queued job, a mail message will be sent to the user who completed the matching process stating that everything has been completed. The other options in the Pharmacy Data Management menu provide methods of maintaining the PHARMACY ORDERABLE ITEM file (#50.7) and the pointer relationships of the other files. File List The following PDM files are exported with the PDM package. File# NAME UPDATE DATA COMES USER DD WITH FILE OVERRIDE 50 DRUG FULL NO 50.4 DRUG ELECTROLYTES FULL NO 50.606 DOSAGE FORM FULL YES (MERGE) NO 50.7 PHARMACY ORDERABLE ITEM FULL NO 51 MEDICATION INSTRUCTION FULL NO 51.1 ADMINISTRATION SCHEDULE FULL YES (MERGE) YES 51.2 MEDICATION ROUTES FULL YES (MERGE) YES 51.5 ORDER UNIT FULL NO 51.7 DRUG TEXT FULL YES YES (OVERWRITE) 52.6 IV ADDITIVES FULL NO 52.7 IV SOLUTIONS FULL NO 54 RX CONSULT FULL (SCREEN) NO 55 PHARMACY PATIENT (Partial DD) PARTIAL NO 59.7 PHARMACY SYSTEM FULL NO The following non-PDM files are exported with the PDM package. File# NAME UPDATE DATA COMES USER DD WITH FILE OVERRIDE 200 NEW PERSON (Partial DD) PARTIAL NO 9009032.3 APSP INTERVENTION TYPE FULL YES NO (OVERWRITE) 9009032.4 APSP INTERVENTION FULL NO 9009032.5 APSP INTERVENTION RECOMMENDATION FULL YES NO (OVERWRITE) (This page included for two-sided copying.) File Descriptions File descriptions can be viewed by using the VA FileMan Print File Entries option. If files are out of sync they will need to be entered individually at the "START WITH NUMBER" prompt. Select OPTION: PRINT FILE ENTRIES OUTPUT FROM WHAT FILE: PHARMACY ORDERABLE ITEM// FILE 1 FILE (490 entries) 2 FILEGRAM ERROR LOG (0 entries) 3 FILEGRAM HISTORY (0 entries) CHOOSE 1-3: 1 SORT BY: NAME// .001 NUMBER START WITH NUMBER: FIRST// 50.7 GO TO NUMBER: LAST// 50.7 WITHIN NUMBER, SORT BY: FIRST PRINT ATTRIBUTE: 1 GLOBAL NAME THEN PRINT ATTRIBUTE: .01 NAME THEN PRINT ATTRIBUTE: DESCRIPTION (word-processing) THEN PRINT ATTRIBUTE: ************************* Heading (S/C): FILE LIST// START AT PAGE: 1// DEVICE: FILE LIST JUL 10,2001 13:18 PAGE 1 GLOBAL NAME NAME DESCRIPTION ------------------------------------------------------------------------------ NUMBER: 50.7 ^PS(50.7, PHARMACY ORDERABLE ITEM Order Entry name for items that can be ordered in the Pharmacy package. (This page included for two-sided copying.) Option Descriptions The option descriptions below were retrieved from VA FileMan and provide the PDM options following the initial installation of the PDM package. ------------------------------------------------------------------ PSS MGR Pharmacy Data Management This menu contains the options necessary to build and maintain the PHARMACY ORDERABLE ITEM file (#50.7), and to also build and maintain the Med. Route/Instructions table. Type: menu Item:PSS PRIMARY/VA GENERIC REPORT Item:PSS VA GENERIC DRUG REPORT Item:PSS CREATE ORDERABLE ITEMS Item:PSS PRE-RELEASE MANUAL MATCH Item:PSS ORDERABLE ITEM STATUS Item:PSSXX MARK Item:PSS DRUG ENTER/EDIT Item:PSS DRG INTER MANAGMENT Item:PSS INTERACTION LOCAL ADD Item:PSS INTERACTION SEVERITY Item:PSSJI ELECTROLYTE FILE Item:PSS LOOK Item:PSS MED. ROUTE/INSTRUCTIONS Item:PSSJU MI Item:PSS ORDERABLE ITEM MANAGEMENT Item:PSS EDIT ORDERABLE ITEMS Item:PSS MAINTAIN ORDERABLE ITEMS Item:PSS ADDITIVE/SOLUTIONS Item:PSS ORDERABLE ITEM REPORT Item:PSS PRIMARY DRUG EDIT Item:PSS SYS EDIT Item:PSS SCHEDULE EDIT ---------------------------------------------------------------- PSS PRIMARY/VA GENERIC REPORT Primary/VA Generic Orderable Item Report This option provides a report of potential Pharmacy Orderable Items based on creating your PHARMACY ORDERABLE ITEM file (#50.7) by Primary Drug name, then VA Generic Name. This report can be run to show drugs that can be auto-created, or be run to show drugs that cant be auto-created. Type: run routine Routine: PRI^PSSMATCH ---------------------------------------------------------------- PSS VA GENERIC DRUG REPORT VA Generic Orderable Item Report This option provides a report of potential Pharmacy Orderable Items based on creating your PHARMACY ORDERABLE ITEM file (#50.7) by VA Generic name only. This report can be run to show drugs that can be auto-created, or run to show drugs that cant be auto-created. Type:run routine Routine: VA^PSSMATCH --------------------------------------------------------------- PSS CREATE ORDERABLE ITEMS Create Pharmacy Orderable Items This option is used to populate the PHARMACY ORDERABLE ITEM file (#50.7). It will also match entries in the IV ADDITIVES file (#52.6), the IV SOLUTIONS file (#52.7), and the DRUG file (#50) to the new PHARMACY ORDERABLE ITEM file (#50.7). This option can only be run one time. It will queue a background job that builds a large TMP global that will be used to create the new file. Do not run this option until you are sure of the method that you want to create the file by. See the Implementation and Maintenance section of this manual, (Steps In Creating Orderable Item File), for more information. Type: run routine Routine: PSSCREAT ---------------------------------------------------------------- ---------------------------------------------------------------- PSS PRE-RELEASE MANUAL MATCH Manually Match Dispense Drugs This option is used to manually match IV Additives, IV Solutions, and Dispense Drugs to Pharmacy Orderable Items. This option must be invoked after the PSS CREATE ORDERABLE ITEMS option has been run to completion. This option will force the matching of all Additives and Solutions with Dispense Drug pointers, and all Dispense Drugs marked with an I, O, or U in the APPLICATION PACKAGES USE field (#63). Every time this option is exited, a check will be done for any unmatched drugs, and an appropriate message will be given to the user. When all drugs are matched that should be matched, a job will be queued that checks for any invalid data. At the completion of this job, a mail message will be sent to the user who completed the matching process. At this time, the pre-release work is finished, and installation of Outpatient Pharmacy V. 7.0 and Inpatient Medications V. 5.0 will be allowed. Type: run routine Routine: PSSPOIM2 ------------------------------------------------------------------ PSS ORDERABLE ITEM STATUS Orderable Item Matching Status This option allows the user to check the status of the manual matching of Orderable Items. Type: run routine PSSOICT ------------------------------------------------------------------ PSSXX MARK CMOP Mark/Unmark (Single Drug) This option allows the user to mark/unmark a single drug for transmission to the CMOP. Type: run routine PSSMARK ----------------------------------------------------------------- PSS DRUG ENTER/EDIT Drug Enter/Edit This option allows the user to edit fields for ALL pharmacy packages if they possess the proper package key. It also will allow the user to match to NDF and Orderable Item. Type:run routine ROUTINE: PSSDEE ----------------------------------------------------------------- PSS DRG INTER MANAGEMENT Drug Interaction Management This is the sub-menu driver for drug interaction maintenance. Type:menu ----------------------------------------------------------------- PSS INTERACTION LOCAL ADD Enter/Edit Local Drug Interaction This option allows pharmacy sites to add local drug ingredient interactions to the DRUG/DRUG INTERACTION file or edit only local drug interactions already in the file. The national entries in the DRUG/DRUG INTERACTION file cannot be edited. This information displays on a screen or prints on a label whenever a pharmacist fills a prescription. Type:action ENTRY ACTION: D ADD^PSSHELP ---------------------------------------------------------------- ----------------------------------------------------------------- PSS INTERACTION SEVERITY Edit Drug Interaction Severity With this option the pharmacy manager can change the drug interaction severity in the DRUG/DRUG INTERACTION file from significant to critical only. Severity cannot be changed from critical to significant. Type:action ENTRY ACTION: D CRI^PSSHELP ---------------------------------------------------------------- PSSJI ELECTROYLYTE FILE Electrolyte File (IV) This option will allow you to alter the contents of the DRUG ELECTORYLYTES file (#50.4). This is the file that is pointed to by the ELECTROLYTE field in both the IV ADDITIVES (#52.6) and IV SOLUTIONS (#52.7) files. Type:run routine Routine: ELECTRO^PSSIVDRG ----------------------------------------------------------------- PSS LOOK Lookup into Dispense Drug File This option provides a report of all information regarding the dispense drug. Type:run routine ROUTINE: PSSLOOK ----------------------------------------------------------------- PSS MED. ROUTE/INSTRUCTIONS Med. Route/Instructions Table Maintenance This option is used to maintain the table of medication routes that will be displayed as defaults in OE/RR, based on dosage form. Type: run routine ROUTINE: ENMR^PSSFILED ----------------------------------------------------------------- PSSJU MI Medication Instruction File Add/Edit The UNIT DOSE package contains a field called SPECIAL INSTRUCTIONS. This field utilizes the abbreviations and expansions of the MEDICATION INSTRUCTION file when printing on various reports. This option allow the user to enter and edit abbreviations and expansions in the MEDICATION INSTRUCTION file and to "flag" those entries for use by the INPATIENT packages only, OUTPATIENT package only, or by both. Type:run routine ROUTINE: ENMI^PSSFILED ---------------------------------------------------------------- PSS ORDERABLE ITEM MANAGEMENT Orderable Item Management This is the sub-menu driver for Orderable Item maintenance. Type:menu --------------------------------------------------------------- PSS EDIT ORDERABLE ITEMS Edit Orderable Items This option is used to edit entries in the PHARMACY ORDERABLE ITEM file (#50.7). All fields except the DOSAGE FORM and IV FLAG fields can be edited. Type: run routine Routine: PSSPOIMO --------------------------------------------------------------- ------------------------------------------------------------------ PSS MAINTAIN ORDERABLE ITEMS Dispense Drug/Orderable Item Maintenance This option is for maintaining the relationship between Dispense Drugs and Orderable Items. This option is used to maintain the relationship between Dispense Drugs and entries in the PHARMACY ORDERABLE ITEM file (#50.7). The Dispense Drug will be prompted for, and then the user can match it to a Pharmacy Orderable Item, or re-match it to a different Pharmacy Orderable Item, depending on whether the Dispense Drug chosen has already been matched. This option is different from the PSS PRE-RELEASE MANUAL MATCH option, where this prompts for Dispense Drug, and this option will remain on the Pharmacy Data Management menu for maintenance purposes. The PSS PRE-RELEASE MANUAL MATCH option is only for the initial set-up of the PHARMACY ORDERABLE ITEM file (#50.7), and should be completed prior to the installations of Inpatient Medications V. 5.0 and Outpatient Pharmacy V. 7.0. Type: run routine Routine: PSSPOIMN --------------------------------------------------------------- PSS ADDITIVE/SOLUTIONS Additive/Solutions, Orderable Items This option is for maintaining the links between entries in the IV ADDITIVES file (#52.6) and the PHARMACY ORDERABLE ITEM file (#50.7),and also between the IV SOLUTIONS file (#52.7) and the PHARMACY ORDERABLE ITEM file (#50.7). Once an Additive or Solution is chosen, the user can then match to an Orderable Item, or re-match to different Orderable Item, depending on whether the Additive or Solution chosen has already been matched. Type: run routine Routine: PSSADDIT ---------------------------------------------------------------- PSS ORDERABLE ITEM REPORT Orderable Item Report This option prints a report that is broken up into three parts. The first part shows all Pharmacy Orderable Items that are linked to IV Additives. The second part shows all Pharmacy Orderable Items linked to IV Solutions. The third part shows all Pharmacy Orderable Items linked to Dispense Drugs. Type: run routine Routine: PSSPOIKA ------------------------------------------------------------------ PSS PRIMARY DRUG EDIT Primary Drug Edit Allows the user to create and edit entries in the PRIMARY DRUG file. Type: run routine Routine: ENPDE^PSSFIL ----------------------------------------------------------------- PSS SYS EDIT Pharmacy System Parameters Edit This will be the edit IV Identifier field that will be displayed with IV Orderable Items. The IV Identifier will be set to IV when the package is initially installed. The Change Type of Order From OERR field is a site parameter that will allow the pharmacist to change the type of order from what is received from OERR. If this field is set to yes, it will be possible to change the order type on orders where the Orderable Item has data in the CORRESPONDING IV ITEM field for unit dose orders or data in the CORRESPONDING UD ITEM for IV orders. Type:run routine Routine: PSSYSP ----------------------------------------------------------------- PSS SCHEDULE EDIT Standard Schedule Edit This option allows the user to edit the set of times associated with the standard dosage administration schedules. This may be used to define the outpatient expansion to be used when the schedule is entered for an outpatient medication order. Type:run routine Routine: ENPSJSE^PSSJEEU The option descriptions below were retrieved from VA FileMan and reflect the PDM options following the installation of patch PSS*1*38. ---------------------------------------------------------------- NAME: PSS MGR MENU TEXT: Pharmacy Data Management TYPE: menu PACKAGE: PHARMACY DATA MANAGEMENT DESCRIPTION: This menu contains options pertaining to maintaining pharmacy data files, creating Pharmacy Orderable Items, and the Medication Route/ Instructions table among other assorted functions. ITEM: PSSXX MARK ITEM: PSS DOSAGES MANAGEMENT ITEM: PSS DRUG ENTER/EDIT ITEM: PSS DRG INTER MANAGEMENT ITEM: PSSJI ELECTROLYTE FILE ITEM: PSS LOOK ITEM: PSSJU MI ITEM: PSS MEDICATION ROUTES EDIT ITEM: PSS ORDERABLE ITEM MANAGEMENT ITEM: PSS ORDERABLE ITEM REPORT ITEM: PSSNFI ITEM: PSS EDIT TEXT ITEM: PSS DRUG TEXT FILE REPORT ITEM: PSS SYS EDIT ITEM: PSS SCHEDULE EDIT ITEM: PSS SYNONYM EDIT ---------------------------------------------------------------- NAME: PSS DOSAGES MANAGEMENT MENU TEXT: Dosages TYPE: menu DESCRIPTION: This menu option contains options that control the editing of dosages. ITEM: PSS DOSAGE CONVERSION ITEM: PSS DOSAGE FORM EDIT ITEM: PSS EDIT DOSAGES ITEM: PSS COMMON DOSAGES ITEM: PSS DOSE FORM/NOUN REPORT ITEM: PSS DOSAGE REVIEW REPORT ---------------------------------------------------------------- NAME: PSS DRG INTER MANAGEMENT MENU TEXT: Drug Interaction Management TYPE: menu DESCRIPTION: This is the sub-menu driver for drug interaction maintenance. ITEM: PSS INTERACTION LOCAL ADD ITEM: PSS REPORT LOCAL INTERACTIONS ---------------------------------------------------------------- NAME: PSS ORDERABLE ITEM MANAGEMENT MENU TEXT: Orderable Item Management TYPE: menu DESCRIPTION: This is the sub-menu driver for Orderable Item maintenance. ITEM: PSS MAINTAIN ORDERABLE ITEMS ITEM: PSS EDIT ORDERABLE ITEMS ITEM: PSS ORDERABLE ITEM DOSAGES ITEM: PSS INSTRUCTIONS/ITEMS REPORT ---------------------------------------------------------------- NAME: PSSXX MARK MENU TEXT: CMOP Mark/Unmark (Single drug) TYPE: run routine LOCK: PSXCMOPMGR DESCRIPTION: This option allows the user to mark/unmark a single drug for transmission to the CMOP. ROUTINE: PSSMARK UPPERCASE MENU TEXT: CMOP MARK/UNMARK (SINGLE DRUG) ---------------------------------------------------------------- NAME: PSS DOSAGE CONVERSION MENU TEXT: Auto Create Dosages TYPE: run routine DESCRIPTION: This option is used to populate the Possible Dose fields and Local Possible Dose fields in the DRUG file. ROUTINE: PSSDOSCR UPPERCASE MENU TEXT: AUTO CREATE DOSAGES ---------------------------------------------------------------- NAME: PSS DOSAGE FORM EDIT MENU TEXT: Dosage Form File Enter/Edit TYPE: run routine DESCRIPTION: This option provides the ability to edit data in the DOSAGE FORM file (#50.606). ROUTINE: DF^PSSDFEE UPPERCASE MENU TEXT: DOSAGE FORM FILE ENTER/EDIT ---------------------------------------------------------------- NAME: PSS EDIT DOSAGES MENU TEXT: Enter/Edit Dosages TYPE: run routine DESCRIPTION: This option allows you to edit Possible Dose fields and Local Possible Dose fields for a selected dispense drug. ROUTINE: DOS^PSSDOSER UPPERCASE MENU TEXT: ENTER/EDIT DOSAGES ---------------------------------------------------------------- NAME: PSS COMMON DOSAGES MENU TEXT: Most Common Dosages Report TYPE: run routine DESCRIPTION: This report displays the most common dosages administered over a specified time period for Unit Dose orders. ROUTINE: EN^PSSCOMMN UPPERCASE MENU TEXT: MOST COMMON DOSAGES REPORT ---------------------------------------------------------------- NAME: PSS DOSE FORM/NOUN REPORT MENU TEXT: Noun/Dosage Form Report TYPE: run routine DESCRIPTION: This report displays the Dosage Forms, along with their associated Nouns and Package Use field. It also displays the Local Possible Dose based on the nouns and instructions. ROUTINE: PSSNOUNR UPPERCASE MENU TEXT: NOUN/DOSAGE FORM REPORT ---------------------------------------------------------------- NAME: PSS DOSAGE REVIEW REPORT MENU TEXT: Review Dosages Report TYPE: run routine DESCRIPTION: This report shows the possible doses and local possible doses for selected dispense drugs. ROUTINE: PSSDOSRP UPPERCASE MENU TEXT: REVIEW DOSAGES REPORT ---------------------------------------------------------------- NAME: PSS DRUG ENTER/EDIT MENU TEXT: Drug Enter/Edit TYPE: run routine DESCRIPTION: This option allows the user to edit fields for ALL pharmacy packages if they possess the proper package key. It also will allow the user to match to NDF and Orderable Item. ROUTINE: PSSDEE UPPERCASE MENU TEXT: DRUG ENTER/EDIT ---------------------------------------------------------------- NAME: PSS INTERACTION LOCAL ADD MENU TEXT: Enter/Edit Local Drug Interaction TYPE: run routine PACKAGE: PHARMACY DATA MANAGEMENT DESCRIPTION: This option allows sites to add their local drug ingredient interactions. ROUTINE: PSSDINT UPPERCASE MENU TEXT: ENTER/EDIT LOCAL DRUG INTERACTION ---------------------------------------------------------------- NAME: PSS REPORT LOCAL INTERACTIONS MENU TEXT: Report of Locally Entered Interactions TYPE: run routine DESCRIPTION: This option allows sites to print a report of locally entered drug interactions and their severity. ROUTINE: PSSDRINT UPPERCASE MENU TEXT: REPORT OF LOCALLY ENTERED INTERACTIONS ---------------------------------------------------------------- NAME: PSSJI ELECTROLYTE FILE MENU TEXT: Electrolyte File (IV) TYPE: run routine DESCRIPTION: This option will allow you to alter the contents of the DRUG ELECTROLYTES file (50.4). This is the file that is pointed to by the ELECTROLYTES sub-file in the IV ADDITIVES (52.6) and IV SOLUTIONS (#52.7) files. EXIT ACTION: K I1 ROUTINE: ELECTRO^PSSVIDRG UPPERCASE MENU TEXT: ELECTROLYTE FILE (IV) ---------------------------------------------------------------- NAME: PSS LOOK MENU TEXT: Lookup into Dispense Drug File TYPE: run routine DESCRIPTION: This option provides a lookup into DISPENSE DRUG file. It displays fields commonly edited. ROUTINE: PSSLOOK UPPERCASE MENU TEXT: LOOKUP INTO DISPENSE DRUG FILE ---------------------------------------------------------------- NAME: PSSJU MI MENU TEXT: Medication Instruction File Add/Edit TYPE: run routine DESCRIPTION: The UNIT DOSE package contains a field called SPECIAL INSTRUCTIONS. This field utilizes the abbreviations and expansions of the MEDICATION INSTRUCTION file when printing on various reports. This option allow the user to enter and edit abbreviations and expansions in the MEDICATION INSTRUCTION file and to "flag" those entries for use by the INPATIENT packages only, OUTPATIENT package only, or by both. ROUTINE: ENMI^PSSFILED UPPERCASE MENU TEXT: MEDICATION INSTRUCTION FILE ADD/EDIT ---------------------------------------------------------------- NAME: PSS MEDICATION ROUTES EDIT MENU TEXT: Medication Route File Enter/Edit TYPE: run routine DESCRIPTION: This option provides the ability to edit data in the MEDICATION ROUTES file (#51.2). ROUTINE: MR^PSSDFEE UPPERCASE MENU TEXT: MEDICATION ROUTE FILE ENTER/EDIT ---------------------------------------------------------------- NAME: PSS EDIT ORDERABLE ITEMS MENU TEXT: Edit Orderable Items TYPE: run routine DESCRIPTION: This option is for editing Pharmacy Orderable Items. ROUTINE: PSSPOIMO UPPERCASE MENU TEXT: EDIT ORDERABLE ITEMS ---------------------------------------------------------------- NAME: PSS MAINTAIN ORDERABLE ITEMS MENU TEXT: Dispense Drug/Orderable Item Maintenance TYPE: run routine DESCRIPTION: This option is for maintaining the relationship between Dispense Drugs and Orderable Items. ROUTINE: PSSPOIMN UPPERCASE MENU TEXT: DISPENSE DRUG/ORDERABLE ITEM MAINTENANCE ---------------------------------------------------------------- NAME: PSS ORDERABLE ITEM DOSAGES MENU TEXT: Orderable Item/Dosages Report TYPE: run routine DESCRIPTION: This option prints a report that displays Inpatient and Outpatient Dosages for each Pharmacy Orderable Item. These are the dosages that will display for selection through Computerized Patient Record System (CPRS) when an Orderable Item is selected for a medication order. ROUTINE: EN^PSSOIDOS UPPERCASE MENU TEXT: ORDERABLE ITEM/DOSAGES REPORT ---------------------------------------------------------------- NAME: PSS INSTRUCTIONS/ITEMS REPORT MENU TEXT: Patient Instructions Report TYPE: run routine DESCRIPTION: This option prints a report that displays Pharmacy Orderable Items, along with the expanded Patient Instructions for each Orderable Item. These Patient Instructions are used as default values for Outpatient orders entered through Computerized Patient Record System (CPRS) and Outpatient Pharmacy. ROUTINE: EN^PSSPNSRP UPPERCASE MENU TEXT: PATIENT INSTRUCTIONS REPORT ---------------------------------------------------------------- NAME: PSS ORDERABLE ITEM REPORT MENU TEXT: Orderable Item Report TYPE: run routine DESCRIPTION: This option lists items from your Pharmacy Orderable Item file, along with the associated Dispense Drugs. ROUTINE: PSSPOIKA UPPERCASE MENU TEXT: ORDERABLE ITEM REPORT ---------------------------------------------------------------- NAME: PSSNFI MENU TEXT: Formulary Information Report TYPE: run routine DESCRIPTION: This option provides a listing of pertinent pharmacy formulary information. ROUTINE: PSSNFI UPPERCASE MENU TEXT: FORMULARY INFORMATION REPORT ---------------------------------------------------------------- NAME: PSS EDIT TEXT MENU TEXT: Drug Text Enter/Edit TYPE: run routine DESCRIPTION: This option enables you to edit entries in the DRUG TEXT file. This file contains drug information, restrictions, and guidelines, etc. ROUTINE: PSSTXT UPPERCASE MENU TEXT: DRUG TEXT ENTER/EDIT ---------------------------------------------------------------- NAME: PSS SYS EDIT MENU TEXT: Pharmacy System Parameters Edit TYPE: run routine DESCRIPTION: This option allows the user to edit the Pharmacy System parameters used in Pharmacy Data Management. ROUTINE: PSSYSP UPPERCASE MENU TEXT: PHARMACY SYSTEM PARAMETERS EDIT ---------------------------------------------------------------- NAME: PSS SCHEDULE EDIT MENU TEXT: Standard Schedule Edit TYPE: run routine DESCRIPTION: Allows user to edit the set of times associated with the standard dosage administration schedules (Q3H,Q8H,TID, etc.). This may be used to define the outpatient expansion to be used when the schedule is entered for an outpatient medication order. ROUTINE: ENPSJSE^PSSJEEU UPPERCASE MENU TEXT: STANDARD SCHEDULE EDIT ---------------------------------------------------------------- NAME: PSS SYNONYM EDIT MENU TEXT: Synonym Enter/Edit TYPE: run routine DESCRIPTION: The option provides easy access to update the synonym information for an entry in the local DRUG file. ROUTINE: PSSSEE UPPERCASE MENU TEXT: SYNONYM ENTER/EDIT The option description below was retrieved from VA FileMan and reflects the new option added to PDM following the installation of patch PSS*1*55. ---------------------------------------------------------------- NAME: PSS DRUG TEXT FILE REPORT MENU TEXT: Drug Text File Report TYPE: run routine DESCRIPTION: This option will display the Drug Text Name, Synonyms, Drug Text, Inactive date if inactive, and list all drug and pharmacy orderable items linked to it. The report is printable for one or all entries. ROUTINE: PSSDTR UPPERCASE MENU TEXT: DRUG TEXT FILE REPORT The option description below was retrieved from VA FileMan and reflects the new option added to PDM following the installation of patch PSS*1*47. Other Language Translation Setup [PSS OTHER LANGUAGE SETUP] option is a stand-alone option that must be assigned to the person(s) responsible for maintaining it. ---------------------------------------------------------------- NAME: PSS OTHER LANGUAGE SETUP MENU TEXT: Other Language Translation Setup TYPE: action PACKAGE: PHARMACY DATA MANAGEMENT DESCRIPTION: This option can be used to enter other language translations that will print on the outpatient pharmacy Rx labels. ENTRY ACTION: D OTHLAN^PSSJEEU UPPERCASE MENU TEXT: OTHER LANGUAGE TRANSLATION SET The option description below was retrieved from VA FileMan and reflects the new option added to PDM following the installation of PSS*1*82. ---------------------------------------------------------------- NAME: PSS MASTER FILE ALL MENU TEXT: Send Entire Drug File to External Interface TYPE: run routine DESCRIPTION: This option will send the entire DRUG file (#50) to an external interface through HL7 messaging. ROUTINE: PSSMSTR UPPERCASE MENU TEXT: SEND ENTIRE DRUG FILE TO EXTER The two option descriptions below were retrieved from VA FileMan and reflect the new options added to PDM following the installation of PSS*1*87. ---------------------------------------------------------------- NAME: PSS WARNING BUILDER MENU TEXT: Warning Builder TYPE: run routine DESCRIPTION: This option will allow you to define a custom warning label list containing entries from both the new warning label source and the old Rx Consult file entries. ROUTINE: PSSWRNB UPPERCASE MENU TEXT: WARNING BUILDER ---------------------------------------------------------------- NAME: PSS WARNING MAPPING MENU TEXT: Warning Mapping TYPE: run routine DESCRIPTION: This option is used to match an entry from the old Rx Consult file to the new commercial data source warning file to aid in using the Warning Builder (to identify local warnings that do not have an equivalent entry in the new commercial data source). The user can also enter a Spanish translation for an Rx Consult file entry, if desired, but whenever possible, the new commercial data source's warnings (English or Spanish depending on the patient setting) should be used. ROUTINE: EDIT^PSSWMAP UPPERCASE MENU TEXT: WARNING MAPPING (This page included for two-sided copying.) Routines The following routines are used by the Pharmacy Data Management package. PSS32P3PSS32P5PSS50PSS50APSS50A1PSS50AQMPSS50ATCPSS50BPSS50B1PSS50B2PSS50CPSS50C1PSS50CMPPSS50DPSS50DATPSS50DOSPSS50EPSS50FPSS50F1PSS50LABPSS50NDFPSS50P4PSS50P66PSS50P7PSS50P7APSS50TMPPSS50WSPSS51PSS51P1PSS51P15PSS51P1APSS51P1BPSS51P1CPSS51P2PSS51P5PSS52P6PSS52P6APSS52P6BPSS52P7PSS52P7APSS54PSS55PSS551PSS55MISPSS59P7PSS781PSSADDITPSSAUTLPSSCHENVPSSCHPREPSSCHPSTPSSCLDRGPSSCOMMNPSSCPRSPSSCPRS1PSSCREATPSSCSPDPSSDAWUTPSSDDUTPSSDDUT2PSSDDUT3PSSDEEPSSDEE1PSSDEE2PSSDELOIPSSDENTPSSDFEEPSSDGUPDPSSDIPSSDINPSSDOSPSSDOSCRPSSDOSCXPSSDOSEDPSSDOSERPSSDOSRPPSSDTRPSSENVPSSENVNPSSFILPSSFILEDPSSFILESPSSGENMPSSGIUPSSGMIPSSGS0PSSGSHPSSHELPPSSHL1PSSHLSCHPSSHLUPSSJEEUPSSJORDFPSSJSPUPSSJSPU0PSSJSVPSSJSV0PSSJXRPSSJXR1PSSJXR10PSSJXR11PSSJXR12PSSJXR13PSSJXR14PSSJXR15PSSJXR16PSSJXR17PSSJXR18PSSJXR19PSSJXR2PSSJXR20PSSJXR21PSSJXR22PSSJXR4PSSJXR5PSSJXR6PSSJXR7PSSJXR8PSSJXR9PSSLABPSSLOOKPSSMARKPSSMATCHPSSMSTRPSSNDCUTPSSNOUNRPSSNTEGPSSOICTPSSOICT1PSSOPKIPSSOPKI1PSSORPHPSSORPH1PSSORUTLPSSOUTSCPSSPKIPIPSSPKIPRPSSPNSRPPSSPOIPSSPOICPSSPOID1PSSPOID2PSSPOID3PSSPOIDTPSSPOIKAPSSPOIMPSSPOIM1PSSPOIM2PSSPOIM3PSSPOIMNPSSPOIMOPSSPOSTPSSPOST1PSSPOST2PSSPOST5PSSPREPSSPRETRPSSQORDPSSREFPSSREMCHPSSSCHEDPSSSOLI1PSSSOLITPSSSPDPSSSUTILPSSSYNPSSUTILPSSUTLA1PSSUTLPRPSSVIDRGPSSVX6PSSVX61PSSVX62PSSVX63PSSVX64PSSVX65PSSVX66PSSWMAPPSSWRNAPSSWRNBPSSWRNEPSSYSP (This page included for two-sided copying.) Exported Options Stand Alone Options All of the PDM options are designed to stand-alone and can be accessed without first accessing the top-level menu. Menus The original PDM menu that would be seen following the initial setup of the PDM package is displayed below. The options needed to build and maintain the PHARMACY ORDERABLE ITEM file (#50.7) will be under the Pharmacy Data Management menu, and will appear as follows. Pharmacy Data Management [PSS MGR] Primary/VA Generic Orderable Item Report [PSS PRIMARY/VA GENERIC REPORT] VA Generic Orderable Item Report [PSS VA GENERIC DRUG REPORT] Create Pharmacy Orderable Items [PSS CREATE ORDERABLE ITEMS] Manually Match Dispense Drugs [PSS PRE-RELEASE MANUAL MATCH] Orderable Item Matching Status [PSS ORDERABLE ITEM STATUS] CMOP Mark/Unmark (Single drug)  [PSSXX MARK] Drug Enter/Edit [PSS DRUG ENTER/EDIT] Drug Interaction Management... [PSS DRG INTER MANAGEMENT] Enter/Edit Local Drug Interaction [PSS INTERACTION LOCAL ADD] Edit Drug Interaction Severity [PSS INTERACTION SEVERITY] Electrolyte File (IV) [PSSJI ELECTROLYTE FILE] Lookup into Dispense Drug File [PSS LOOK] Med. Route/Instructions Table Maintenance [PSS MED. ROUTE/INSTRUCTIONS] Medication Instruction File Add/Edit [PSSJU MI] Orderable Item Management... [PSS ORDERABLE ITEM MANAGEMENT] Edit Orderable Items [PSS EDIT ORDERABLE ITEMS] Dispense Drug/Orderable Item Maintenance [PSS MAINTAIN ORDERABLE ITEMS] Additive/Solutions, Orderable Items [PSS ADDITIVE/SOLUTIONS] Orderable Item Report [PSS ORDERABLE ITEM REPORT] Primary Drug Edit [PSS PRIMARY DRUG EDIT] Pharmacy System Parameters Edit [PSS SYS EDIT] Standard Schedule Edit [PSS SCHEDULE EDIT]  Locked: PSXCMOPMGR Without the PSXCMOPMGR key XE "PSXCMOPMGR key" , the CMOP Mark/Unmark (Single drug) option will not appear on your menu. The PDM menu that was exported with the original PDM package has been modified to include subsequent changes and patches, including the changes resulting from the Pharmacy Ordering Enhancements project. The PDM menu up to and including PSS*1*87 appears below. PSS*1*87 was the last patch to affect a change to the PDM menu. Pharmacy Data Management [PSS MGR] Dosages [PSS DOSAGES MANAGEMENT] Auto Create Dosages [PSS DOSAGE CONVERSION] Dosage Form File Enter/Edit [PSS DOSAGE FORM EDIT] Enter/Edit Dosages [PSS EDIT DOSAGES] Most Common Dosages Report [PSS COMMON DOSAGES] Noun/Dosage Form Report [PSS DOSE FORM/ NOUN REPORT] Review Dosages Report [PSS DOSAGE REVIEW REPORT] Drug Enter/Edit [PSS DRUG ENTER/ EDIT] Drug Interaction Management [PSS DRG INTER MANAGEMENT] Enter/Edit Local Drug Interaction [PSS INTERACTION LOCAL ADD] Report of Locally Entered Interactions [PSS REPORT LOCAL INTERACTIONS] Electrolyte File (IV) [PSSJI ELECTROLYTE FILE] Lookup into Dispense Drug File [PSS LOOK] Medication Instruction File Add/Edit [PSSJU MI] Medication Route File Enter/Edit [PSS MEDICATION ROUTES EDIT] Orderable Item Management [PSS ORDERABLE ITEM MANAGEMENT] Edit Orderable Items [PSS EDIT ORDERABLE ITEMS] Dispense Drug/Orderable Item Maintenance [PSS MAINTAIN ORDERABLE ITEMS] Orderable Item/Dosages Report [PSS ORDERABLE ITEM DOSAGES] Patient Instructions Report [PSS INSTRUCTIONS/ ITEMS REPORT] Orderable Item Report [PSS ORDERABLE ITEM REPORT] Formulary Information Report [PSSNFI] Drug Text Enter/Edit [PSS EDIT TEXT] Drug Text File Report [PSS DRUG TEXT FILE REPORT] Pharmacy System Parameters Edit [PSS SYS EDIT] Standard Schedule Edit [PSS SCHEDULE EDIT] Synonym Enter/Edit [PSS SYNONYM EDIT] Other Language Translation Setup [PSS OTHER LANGUAGE SETUP] Controlled Substances/PKI Reports [PSS CS/PKI REPORTS] DEA Spec Hdlg & CS Fed Sch Discrepancy [PSS DEA VS CS FED. SCH. DISCR.] Controlled Substances Not Matched to NDF [PSS CS NOT MATCHED TO NDF] CS (DRUGS) Inconsistent with DEA Spec Hdlg [PSS CS DRUGS INCON WITH DEA] CS (Ord. Item) Inconsistent with DEA Spec Hdlg [PSS CS (OI) INCON WITH DEA] Send Entire Drug File to External Interface [PSS MASTER FILE ALL] CMOP Mark/Unmark (Single drug) [PSSXX MARK]  Warning Builder [PSS WARNING BUILDER] Warning Mapping [PSS WARNING MAPPING]  Locked: PSXCMOPMGR Without the PSXCMOPMGR key XE "PSXCMOPMGR key" , the CMOP Mark/Unmark (Single drug) option will not appear on your menu.  A post-installation routine for patch PSS*1*61 identifies those drugs with discrepancies between the CS FEDERAL SCHEDULE field (#19) of the VA PRODUCT file (#50.68) and DEA, SPECIAL HDLG field (#3) of the DRUG file (#50). Four mail messages are generated and sent to the installer and to holders of the PSNMGR keys: These mail messages can be re-generated on demand using the Controlled Substances/PKI Reports [PSS CS/PKI REPORTS] menu added with this patch. The post-install also checks to see if the DEA, SPECIAL HDLG field (#3) of the DRUG file (#50) is null and if the drug is matched to an entry in the VA PRODUCT file (#50.68), and the CS FEDERAL SCHEDULE field (#19) of the VA PRODUCT file (#50.68) has data, then it updates the DEA, SPECIAL HDLG field (#3) of the DRUG file (#50) with the DEA, SPECIAL HDLG code mapped to corresponding CS FEDERAL SCHEDULE code. (This page included for two-sided copying.) HL7 Messaging with an External System New Protocol A new protocol, PSS HUI DRUG UPDATE, is exported and has been created to generate HL7 messages when new drugs are added to the DRUG file (#50) and existing entries are updated. This protocol is exported with the text DELETE ONLY TO SEND DRUG UPDATE MESSAGES in the DISABLE field (#2) of the PROTOCOL file (#101). To activate the sending of these HL7 messages, the text from the DISABLE field (#2) of the PROTOCOL file (#101) must be deleted and at least one receiving protocol added as a subscriber. The drug data elements included in the HL7 message are defined in the table below. HL7 Drug Message Segment Definition Table When the PSS HUI DRUG UPDATE protocol is enabled, the following table defines the data elements sent in each segment of the HL7 drug message. SegmentPieceField NameHL7 TBL # or Data TypeDescriptionMSH1|STField Separator2^~\&STEncoding Characters3PharmacyNo suggested valueSending Application9MFN0076Message TypeMFI150^DRUG^99PSD0175Master File ID3UPD0178File-Level Event Code6NE0179Response Level CodeMFA1MUP/MAD0180UPDATE/ADDMFE1MUP/MAD0180UPDATE/ADD4IEN^DRUG NAME^99PSDFile 50 EntryZPA1NDCSTNational Drug Code2LOCAL NON-FORMULARYCEIf 1 true3INACTIVE DATEDTHL7 Format (YYYYMMDD)4APPLICATION PACKAGE USESTUsed by what packages5MESSAGESTInfo on drug6VA CLASSIFICATIONSTVA Class7DEA SPECIAL HDLGSTHow drug is dispense based on DEA codes8FSNST Federal Stock #9WARNING LABELSTDrug Warnings for patient10VISN NON-FORMULARCEIf 1 trueZPB1PHARMACY ORDERABLE ITEMCEIEN^OI tied to dispense drug^PSD50.72DOSAGE FORMSTIEN^Dosage Form associated with OI^PSD50.6063MEDICATION ROUTESTIEN^Med Route associated with OI^PSD51.24PSNDF VA PRODUCT NAME ENTRYCEIEN^VA PRODUCT NAMES^PSD50.685DISPENSE UNITSTDispense Unit for a drug6CMOP DISPENSECE1 or 07OP EXTERNAL DISPENSECE1 or 08EXPIRATION DATEDTHL7 Format (YYYYMMDD)9LAB TEST MONITORCEIEN^Lab Test^LAB60ZPC1SPECIMEN TYPECEIEN^ SPECIMEN TYPE^LAB612MONITOR ROUTINESTProgram that runs to find lab test and results3LAB MONITOR MARKCEIf 1 true4STRENGTHNMDose of drug5UNITCEIEN^Unit of measure^PSD50.6076PRICE PER ORDER UNITNM7PRICE PER DISPENSE UNITNM[{ZPD}] 1SYNONYMSTTrade Name2NDC CODESTNational Drug Code3INTENDED USECE CE^INTENTED USE SegmentPieceField NameHL7 TBL # or Data TypeDescription4VSNSTVendor Stock Number5ORDER UNITCEIEN^ABBREVIATION^EXPANSION ^PSD51.56PRICE PER ORDER UNITNM7DISPENSE UNITS PER ORDER UNITNM8PRICE PER DISPENSE UNITNM9VENDORSTVendor[{ZPE}]1ACTIVITY LOGDTHL7 Format YYYYMMDDHHMM[SS]-ZZZZ2REASONCEE^EDIT3INITIATOR OF ACTIVITYCEIEN^NEW PERSON^VA2004FIELD EDITEDST5NEW VALUEST6NDF UPDATEST[{ZPF}]1DISPENSE UNITS PER DOSENM2DOSENM3PACKAGECECE^PACKAGE(S)4BCMA UNITS PER DOSENM[{ZPG}]1CLOZAPINE LAB TESTCEIEN^LAB TEST^LAB602MONITOR MAX DAYSNM3SPECIMEN TYPECEIEN^ SPECIMEN TYPE^LAB614TYPE OF TESTCE1^WBC or 2^ANC[{ZPH}]1LOCAL POSSIBLE DOSAGESTFREE TEXT2PACKAGECECE^PACKAGE(S)3BCMA UNITS PER DOSENM New Protocol Two new protocols, PSS EXT MFU CLIENT and PSS EXT MFU SERVER, are exported and have been created to generate HL7 messages when new drugs are added to the DRUG file (#50) and existing entries are updated. These protocols can only be activated by setting the following parameters in the OUTPATIENT SITE file (#59): AUTOMATED DISPENSE field (#105) needs to be set to 2.4. ENABLE MASTER FILE UPDATE field (#105.2) needs to be set to YES. LOGICAL LINK field (#2005) needs to be set to PSO DISP. DISPENSE DNS NAME field (#2006) needs to be set to the dispensing system DNS name (for example, dispensemachine1.vha.med.va.gov). DISPENSE DNS PORT field (#2007) needs to be set to the dispensing system port number. Specific Transaction XE "Specific Transaction" The Pharmacy/Treatment Encoded Order Message is as follows: MFN Master File Notification Message MSH Message Header MFI Master File Identifier {MFE Master File Entry {{ZPA} Drug File Information {RXD} Pharmacy/Treatment Dispense {OBR}} Observation Request } Example: MSH|~^\&|PSS VISTA|521~FO-BIRM.VHA.MED.VA.GOV~DNS|PSS DISPENSE|~DISPENSE1.VHA.MED.VA.GOV:9300~DNS|20030701||MFN~M01~MFN_M01|10001|P|2.4|||AL|AL MFI|50~DRUG~99PSD||UPD|||NE MFE|MUP|||PROPANTHELINE 15MG TAB ZPA|PROPANTHELINE 15MG TAB|N|LFN~Local Non-Formulary~Pharm Formulary Listing|20031226|Take with food|DE200|6|P|50~6505-00-960-8383~LPS50|8~NO ALCOHOL~LPS54|229~Bacitracin~LPSD50.7|3~CAP,ORAL~LPSD50.606|15~IV PUSH~LPSD51.2|3643~ATROPINE SO4 0.4MG TAB~LPSD50.68|OP~OP Dispense~99OP|20030830|9~Rubella~LLAB60|72~Hair of Scalp~LLAB61|PSOCLO1|N|100|20~MG~LPSD50.607|4.28&USD~UP|15.64&USD~UP|TAB|2|BLUE HOUSE VENDOR|0010-0501-33|TRADENAME RXD||||1|||||1|||~P&200&LPSD50.0903||||||||||||O OBR||||1102~ACETAZOLAMIDE~LLAB60|||||||||||70&NECK&LLAB61|||||||||WBC|||7 HL7 Drug Message Segment Definition Table When the PSS EXT MFU SERVER protocol is enabled, the following table defines the data elements sent in each segment of the HL7 drug message. Segments used in the Master File Update message: SEGMENTSEQ#LENDTR/ORP/#TBL#ELEMENT NAMEEXAMPLEMSH11STRField Separator|24STREncoding Characters~^\&3180HDR0361Sending ApplicationPSS VISTA4180HDR0362Sending Facility station ID and station DNS name521~FO-BIRM.MED.VA.GOV~DNS5180HDR0361Receiving ApplicationPSS DISPENSE6180HDR0362Receiving Facility DNS name and port of dispensing machine~DISPENSE.VHA.MED.VA.GOV:9300~DNS726TSDate/Time of Message20040405152416915CMR0076Message TypeMFN_M011020STRMessage Control ID10001113PTR0103Processing IDP123VIDR0104Version ID2.4152ID0155Accept Ack. TypeAL162ID0155Application Ack TypeALMFI1250CER0175Master File Identifier50^DRUG^99PSD33IDR0178File-Level Event CodeUPD62IDR0179Response Level CodeNEMFE13IDR0180Record-Level Event CodeMUP4200VariesRPrimary Key Value MFEPROPANTHELINE 15MG TABZPA1200VariesRPrimary Key Value ZPAPROPANTHELINE 15MG TAB21IDR0136Is SynonymN3200CERFormulary ListingLFN~Local Non-Formulary~Pharm Formulary Listing410DTOInactive Date200312265200STODrug MessageTake with Food630STODrug ClassificationDE200710STODEA-Schedule Code681STODEA-Drug TypeP9100CERStock Number50~6505-00-960-8383~LPS5010100CEOWarning Label8~NO ALCOHOL~LPS54 Segments used in the Master File Update message: (continued) SEGMENTSEQ#LENDTR/ORP/#TBL#ELEMENT NAMEEXAMPLE11100CEOPharmacy Orderable Item229~Bacitracin~LPSD50.712100CEODosage Form3~CAP,ORAL~LPSD50.60613100CEOMedication Route15~IV PUSH~LPSD51.214100CEODrug Name Identifiers3643~ATROPINE SO4 0.4MG TAB~LPSD50.6815100CEODispense FlagsOP~OP Dispense~99OP1615DTODrug Expiration Date2003083017100CEOLab Test Monitor9~Rubella~LLAB6018100CEOSpecimen Type72~Hair of Scalp~LLAB611910CEOMonitor RoutinePSOCLO1201IDOLab Monitor MarkN2150NMOStrength10022250CERUnit20~MG~LPSD50.6072350CPRPrice Per Order Unit4.28&USD~UP2450CPRPrice Per Dispense Unit15.64&USD~UP2525STODispense UnitTAB2650NMODispense Units Per Order Unit22750STOVendorBLUE HOUSE VENDOR2812STONDC Code0010-0501-332925STOIntended UseTRADE NAMERXD420NMRActual Dispense Amount1820NMRDispense Notes11210CQOTotal Daily Dose~P&200&LPSD50.0903242IDRDispense Package MethodOOBR4250CEOUniversal Service Identifier1102~ACETAZOLAMIDE~LLAB6015300CMOSpecimen Source70&NECK&LLAB61243IDRDiagnostic Serv Sect IDWBC27200TQOQuantity/Timing7 Notes pertaining to some of the data elements: [MSH-3] Sending Application is the station ID along with the DNS name of the sending facility. [MSH-5] Receiving Application is the DNS name and DNS port number of the dispensing application. [MSH-10] Message Control ID is the number that uniquely identifies the message. It is returned in MSA-2 of the dispense completion message. [MFI-1] Master File Identifier is hard-coded to 50~DRUG~99PSD. [MFE-1] Record-Level Event Code can be either MUP for Update or MAD for Add. [MFE-4] Primary Key Value MFE is the GENERIC NAME field (#.01) from the DRUG file (#50). [ZPA-1] Primary Key Value ZPA will be the generic name of the drug first and then all synonyms will follow in consecutive ZPA segments. [ZPA-2] Is Synonym is set to Y or N depending on whether the primary key is a synonym. [ZPA-3] Formulary Listing will contain LFN and/or VISN is the formulary is not to appear on the Local or VISN formulary. [ZPA-9] Stock Number is the FSN field (#6) from the DRUG file (#50) or the VSN field (#400) from the SYNONYM subfile (#50.1) of the PRESCRIPTION file (#50). [ZPA-15] Dispense Flags will indicate if this drug may be dispensed to an external interface and if it is marked to be dispensed at a Consolidated Outpatient Pharmacy (CMOP). If both are yes, the answer would be OP~OP Dispense~Pharm dispense^CMOP~CMOP dispense~Pharm dispense flag. [ZPA-29] Intended User will be TRADE NAME, QUICK CODE, DRUG ACCOUNTABILITY or CONTROLLED SUBSTANCES. [RXD-4] Actual Dispense Amount is the BCMA UNITS PER DOSE field (#3) from the POSSIBLE DOSAGES file (#50.0903). [RXD-9] Dispense Notes is the DISPENSE UNITS PER DOSE field (#.01) from the POSSIBLE DOSAGES file (#50.0903). [RXD-12] Total Daily Dose will be either P for Possible Dosages or LP for Local Possible Dosages. [OBR-4] Universal Service Identifier is used for Clozapine Lab Test. [OBR-15] Specimen Source is used for Clozapine Specimen Type. [OBR-24] Diagnostic Serv Sect ID is used for Clozapine Type of Test. [OBR-27] Quantity/Timing is used to encode Monitor Max days from the CLOZAPINE LAB TEST file (#50.02). Data Archiving and Purging There are no archiving and purging functions necessary with this release of the PDM package. Callable Routines/Entry Points/Application Program Interfaces (APIs) APIs, callable routines, and entry points can be viewed by first choosing the DBA menu option on FORUM and then choosing the Integration Agreements Menu option. For detailed information on all supported Pharmacy Data Management APIs, see the Pharmacy Re-Engineering (PRE) Application Program Interface (API) Manual posted on the VistA Documentation Library (VDL) at  HYPERLINK "http://www.va.gov/vdl/" http://www.va.gov/vdl/. Medication Routes The following paragraphs provide an explanation of medication route information. If there is one and only one orderable item in the IV order, the Pharmacy Orderable Item file (50.7) will be checked to see if there is a default med route. Additionally, any med route defined for the dosage form of the orderable item will be checked. Duplicate entries will be filtered by inpatient pharmacy. The list of possible med routes sent back to CPRS will include the default med route (if defined), as well as any other med routes defined for the dosage form. If there is more than one orderable item on the IV order, the Pharmacy Orderable Item file will be checked for each orderable item to see if a default is defined. This default will be pooled with the other possible med routes for each dosage form for each orderable item. Duplicates will be filtered by inpatient pharmacy. Regardless of whether all orderable item defaults match or not, a default med route will not be marked as a default if there is more than one orderable item on the order. The list of possible med routes returned to CPRS will include only those med routes that every orderable item in the order shares in common. Administration Scheduling The following rules apply to administration scheduling. If there is a duplicate schedule, and if one of them contains ward-specific administration times for the ward location of the patient, the schedule returned for inclusion in the array of selectable schedules in CPRS will be the one with the ward-specific administration times. If no duplicate has ward-specific administration times for the ward location of the patient, the schedule with the lowest IEN number will be returned. If both (or more than one) duplicate schedules have ward-specific administration times for the ward location of the patient, the schedule with the lowest IEN number in the ADMINISTRATION SCHEDULE file #51.1 will be the schedule in the array returned to CPRS. External Relations Integration Agreements IAs can be viewed by first choosing the DBA option on FORUM and then the Integration Agreements Menu option. Example: DBA Option Select Primary Menu Option: DBA Select DBA Option: INTEGration Agreements Menu Select Integration Agreements Menu Option: Custodial Package Menu Select Custodial Package Menu Option: ACTIVE by Custodial Package Select PACKAGE NAME: PHARMACY DATA MANAGEMENT PSS DEVICE: HOME// Internal Relations All PDM options can function independently. Package-Wide Variables There are no package-wide variables for this version. Package Requirements The initial PDM module relies on, at least, the following external packages to run effectively. Package Minimum version needed National Drug File V. 3.15 Outpatient Pharmacy V. 6.0 Inpatient Medications V. 4.5 Kernel V. 8.0 (plus all patches, particularly XU*8*28) VA FileMan V. 21.0 (plus all patches) The PDM module up to and including the release of PSS*1*68, relies on, at least, the following external packages to run effectively. Package Minimum version needed National Drug File V. 4.0 Outpatient Pharmacy V. 7.0 Inpatient Medications V. 5.0 Kernel V. 8.0 VA FileMan V. 22 (This page included for two-sided copying.) Additional Information SAC Exemptions There are no Standards and Conventions (SAC) exemptions for this package. Cross-Reference Logic To Keep Orderable Items Up To Date With the introduction of PSS*1*38, a new process for keeping Orderable Items updated was implemented. The process is explained in detail in the section below. Anytime specific fields are edited, or a pointer to the PHARMACY ORDERABLE ITEM file (#50.7) changes, the Orderable Item (OI) must be updated and sent to CPRS. Two different situations can precipitate these changes. Both situations are explained in detail here. The first situation occurs when a field is edited that can possibly affect the status of the Orderable Item, but no Orderable Item pointers change. In this situation, the old Orderable Item is the same as the new Orderable Item. In these cases, the kill logic will be the same as the set logic. The kill and set logic will simply pass in the Orderable Item to the routine that checks all IV Additives/IV Solutions/Dispense Drugs matched to the Orderable Item, does all the necessary updates (Inactivation date, Supply flag, Non-formulary, Base, Additive), and then sends the Master File Update to CPRS on that Orderable Item. This type of update occurs when the fields listed below are edited. File 50: DEA Special Hdlg File 50: Inactivation Date File 50: Application Packages Use File 50: Local Non-Formulary File 50.7: Inactivation Date File 52.6: Inactivation Date File 52.6: Used in IV Fluid Order Entry File 52.7: Inactivation Date File 52.7: Used in IV Fluid Order Entry The second situation occurs when pointers to the PHARMACY ORDERABLE ITEM file (#50.7) are changed. IV Additives, IV Solutions and the Dispense Drug always point to the same Orderable Item. That Orderable Item is, in turn, pointed to by the IV Additive or IV Solution. So, the fields that may be affected include the Orderable Item pointer in the DRUG file (#50) and the Generic Drug pointer in the IV ADDITIVES file (#52.6) and the IV SOLUTIONS file (#52.7). File 50: Orderable Item Pointer File 52.6: Generic Drug Pointer File 52.7: Generic Drug Pointer The initial change is to make the Orderable Item pointers in the IV ADDITIVES file (#52.6) and the IV SOLUTIONS file (#52.7) uneditable. The software will now control those pointers. Scenario 1: The Orderable Item Pointer Is Changed For A Dispense Drug In Example 1, the Orderable Item pointer is changed for a Dispense Drug. In this case, any Orderable Item pointers must be updated for entries in the IV ADDITIVES file (#52.6) and the IV SOLUTIONS file (#52.7) that point to that Dispense Drug. After these pointers have been updated, the Orderable Item must be updated for the old Orderable Item with what will point to it after the matching. The Orderable Item must also be updated for the new Orderable Item after the matching. And these pharmacy Orderable Item updates must be sent to CPRS as part of the Master File Update. To accomplish this the following steps must be completed. Add a Cross-Reference on the Orderable Item pointer in the DRUG file (#50) that will hard set one Cross-Reference in the ORDERABLE ITEM file (#50.7) and two Cross-References in the DRUG file (#50) as follows. Orderable Item: ^PS(50.7,"A50",Orderable Item IEN, Dispense Drug IEN)="" Drug file: ^PSDRUG("A526", Dispense Drug IEN, Additive IEN,)="" Drug file: ^PSDRUG("A527", Dispense Drug IEN, Solution IEN,)="" The Orderable Item Cross-Reference allows access to Dispense Drugs matched to an Orderable Item. The two DRUG file (#50) Cross-References allow access to Solutions and Additives linked to Dispense Drugs. An "A50" Cross-Reference will also be added on the NAME field (# .01) of the PHARMACY ORDERABLE ITEM file (#50.7) containing a "Quit" command for the set and kill logic for documentation purposes only. When the Orderable Item pointer of a Dispense Drug changes, only one Cross-Reference is needed on that field to perform the following actions. Kill Logic: This command performs a hard kill of the "A50" Cross-Reference in the PHARMACY ORDERABLE ITEM file (#50.7) for that Dispense Drug using old value (X) and DA, where X equals the OI IEN and DA equals the Dispense Drug IEN. The two DRUG file (#50) Cross-References will not change. After the hard kill is completed, a Master File Update is performed for the old Orderable Item. The logic for all Dispense Drugs/IV Additives/IV Solutions matched to the Orderable item is executed by looping the three Cross-References to find all entries in all three files matched to the Orderable Item. Also in the Kill logic, the Orderable Item pointer is set to null and the Orderable Item pointer Cross-Reference is killed for any IV Additives or IV Solutions matched to the Dispense Drug. Set Logic: Using the New Value (X), where X equals the OI IEN, the "A50" Cross-Reference is hard set in the PHARMACY ORDERABLE ITEM file (#50.7). The Master File Update is then performed for the new Orderable Item. The logic for all Dispense Drugs/IV Additives/IV Solutions matched to the Orderable Item is executed by looping on the three Cross-References to find all entries in all three files matched to the Orderable Item. The Orderable Item pointer and the Orderable Item pointer Cross-References are then hard set for all IV Additives and IV Solutions that have been matched to the Dispense Drug with new value (X). Example 1: Additives/Solution Dispense Drugs: Orderable Item: IEN 3 points to => IEN 100 points to => 500 IEN 4 points to => IEN 100 points to => 500 IEN 5 points to => IEN 100 points to => 500 IEN 10 points to => IEN 200 points to => 500 Cross-References are: ^PS(50.7,"A50",500,100)="" ^PS(50.7,"A50",500,200)="" ^PSDRUG("A526",100,3)="" ^PSDRUG("A526",100,4)="" ^PSDRUG("A526",100,5)="" ^PSDRUG("A527",200,10)="" Orderable Item 500 is pointed to by Dispense Drugs 100 and 200, and by IV Additives 3, 4, and 5, and IV Solution 10. (If the LOCAL NON-FORMULARY field (#51) in the DRUG file (#50) is edited, the software will obtain the OI pointer 500 and execute the OI logic by looping on 500 in the "A50" Cross-Reference of the PHARMACY ORDERABLE ITEM file (#50.7). As it references each entry, the OI logic is executed by looping on the A526 and A527 Cross-references on the DRUG file (#50) before going to the next Orderable Item pointer in the "A50" Cross-reference in the PHARMACY ORDERABLE ITEM file (#50.7). For Example 1 above, the software will find in the first "A50" Cross-Reference for OI 500, Dispense Drug 100. The software will then loop through all the A526 and A527 Cross-References in the DRUG file (#50) to find the IV Additives 3, 4 and 5. In the second A50 Cross-Reference for OI 500, Dispense Drug 200 is identified. The software will again loop through any existing A526 and A527 Cross-references in the DRUG file (#50) to find IV Solution 10. If the Orderable Item pointer for Dispense Drug 100 is edited from 500 to 600, the Cross-Reference in the DRUG file (#50) the following logic will be performed. Kill Logic Kill the Cross-Reference ^PS(50.7,"A50",500,100) using DA and old value (X=500), where DA equals the IEN of the Dispense Drug and X equals the IEN of the Orderable Item The Cross-References would now be as follows. ^PS(50.7,"A50",500,200)="" ^PSDRUG("A526",100,3)="" ^PSDRUG("A526",100,4)="" ^PSDRUG("A526",100,5)="" ^PSDRUG("A527",200,10)="" The A50 and A527 Cross-references now identify Orderable Item 500 to be pointed to by Dispense Drug 200 and IV Solution 10. The Orderable Item update for OI 500 is then performed for Dispense Drug 200 and IV solution 10. While still in the Kill logic, the PHARMACY ORDERABLE ITEM field (#15) in the IV ADDITIVES file (#52.6) is set to null for IV Additives 3, 4, and 5. This action results in the deletion of Cross-References on the PHARMACY ORDERABLE ITEM field (#15) of the IV ADDITIVES file (#52.6). Set Logic The A50 Cross-Reference in the PHARMACY ORDERABLE ITEM file (#50.7) for the new Orderable Item 600 is set as follows. ^PS(50.7,"A50",500,200)="" ^PS(50.7,"A50",600,100)="" ^PSDRUG("A526",100,3)="" ^PSDRUG("A526",100,4)="" ^PSDRUG("A526",100,5)="" ^PSDRUG("A527",200,10)="" The Orderable Item logic is executed on the new OI 600 by looping on the "A50" Cross-Reference, to get the Dispense Drug pointer of 100. The software then loops through any existing A526 and A527 Cross-References to get IV Additives 3, 4 and 5. The value of the PHARMACY ORDERABLE ITEM (#15) field in the IV ADDITIVES file (#52.6) for IV Additives 3, 4, and 5 is set to 600. Existing Cross-References are also set to reflect this change. Scenario 2: The Dispense Drug Pointer Is Edited For An IV Additive Or IV Solution If the Dispense Drug is changed for an IV Additive or IV Solution, the Cross-References on the PHARMACY ORDERABLE ITEM field in the IV ADDITIVES file (#52.6) and IV SOLUTION file (#52.7) will perform the following set and kill logic. Kill Logic First, the "A526" or "A527" Cross-References in the DRUG file (#50) will be killed. Then, using DA, which is equal to the Orderable Item IEN, the software will get the old Orderable Item pointer value and perform the Orderable Item logic on the old Orderable Item. Subsequently, the value in the PHARMACY ORDERABLE ITEM field for the IV Additive and/or IV Solution will be set to null and the existing Cross-References on this field will be killed. Set Logic First, the "A526" or "A527" Cross-References in the DRUG file (#50) will be set. Then Using X, which is equal to the Dispense Drug IEN, the software will identify the new Orderable Item in the DRUG file (#50) and perform the OI logic on that Orderable Item. The PHARMACY ORDERABLE ITEM field in the IV ADDITIVES file (#52.6) and IV SOLUTION file (#52.7) will be set to the new value and existing Cross-References will be also set. Users can first check the new Dispense Drug, and if the Orderable Item does not change by rematching the Additive/Solution to the new Dispense Drug, they can choose the QUIT command. Example 2: IV Additives/IV Solution Dispense Drugs Orderable Item IEN 3 points to => IEN 100 points to => 500 IEN 4 points to => IEN 100 points to => 500 IEN 5 points to => IEN 100 points to => 500 IEN 10 points to => IEN 200 points to => 500 Cross-References ^PS(50.7,"A50",500,100)="" ^PS(50.7,"A50",500,200)="" ^PSDRUG("A526",100,3)="" ^PSDRUG("A526",100,4)="" ^PSDRUG("A526",100,5)="" ^PSDRUG("A527",200,10)="" For example, the USED IN IV FLUID ORDER ENTRY field (#17) in the IV ADDITIVES file (#52.6) for IV Additive 3 could be edited. The Orderable Item that the IV Additive points to in this case, is 500. Both the Kill and Set logic (same logic) for the OI 500 is updated by looping through the "A50" Cross-Reference in the PHARMACY ORDERABLE ITEM file (#50.7), finding each Dispense Drug IEN, and going through the "A526" and "A527" Cross-References in the DRUG file (#50) for that Dispense Drug. This process is then repeated for the next Dispense drug identified in the A50 Cross-Reference If the DRUG file (#50) pointer for IV Additive 3 were changed from Dispense Drug 100 to Dispense Drug 900, the Cross-Reference on the Dispense Drug Pointer would be killed. Kill Logic Using old value of X, which equals the Dispense Drug 100 and DA, which equals the IV ADDITIVE 3, the software would kill Cross-Reference ^PSDRUG("A526",100,3) with the following Cross-References remaining. ^PS(50.7,"A50",500,100)="" ^PS(50.7,"A50",500,200)="" ^PSDRUG("A526",100,4)="" ^PSDRUG("A526",100,5)="" ^PSDRUG("A527",200,10)="" Using DA, the software would get the old Orderable Item pointer of 500 and execute the Orderable Item logic for Dispense Drugs 100, IV Additives 4 and 5, Dispense Drug 200, and IV Solution 10. The value for the PHARMACY ORDERABLE ITEM field (#15) in the IV ADDITIVES file (#52.6) would be set to null and Cross-References on this field would be deleted. Set Logic Using new value X, where X equals the Dispense Drug 900, the software would set the new "A526" Cross Reference as ^PSDRUG("A526",900,3)="", The updated Cross-References are as follows ^PS(50.7,"A50",500,100)="" ^PS(50.7,"A50",500,200)="" ^PSDRUG("A526",100,4)="" ^PSDRUG("A526",100,5)="" ^PSDRUG("A526",900,3)="" ^PSDRUG("A527",200,10)="" Using new value of X, where X equals the Dispense Drug 900, the software gets the Orderable Item pointer for Dispense Drug 900, in this example, Orderable Item 2000. The applicable Cross-References would be the following. ^PS(50.7,"A50",500,100)="" ^PS(50.7,"A50",500,200)="" ^PS(50.7,"A50",2000,900)="" ^PSDRUG("A526",100,4)="" ^PSDRUG("A526",100,5)="" ^PSDRUG("A526",900,3)="" ^PSDRUG("A527",200,10)="" The software performs the OI update for Orderable Item 2000, with Dispense Drug 900 and IV Additive 3. The PHARAMCY ORDERABLE ITEM field (#15) value in the IV ADDITIVES file (#52.6) is set to 2000. The corresponding Cross-References on this field are also set. Security Guide (This page included for two-sided copying.) Security Management The PDM package does not contain any VA FileMan security codes except for programmer security (@) on the data dictionaries for the PDM files. Security with respect to standard options in the module is implemented by carefully assigning options to users and by the use of security keys. Mail Groups and Alerts No mail groups or alerts are required by PDM. Remote Systems PDM does not transmit data to any remote system or facility. Archiving/Purging There are no archiving and purging functions necessary with the PDM package. Contingency Planning Sites utilizing the PDM package should develop a local contingency plan to be used in the event of product problems in a live environment. The facility contingency plan must identify the procedure for maintaining functionality provided by this package in the event of system outage. Field station Information Security Officers (ISOs) may obtain assistance from their Regional Information Security Officer (RISO). Interfacing There are no specialized products embedded within or required by the PDM package. Electronic Signatures No electronic signatures are utilized in the PDM package. (This page included for two-sided copying.) Menus The Pharmacy Data Management menu that is exported with the initial release of the PDM package is as follows. *Primary/VA Generic Orderable Item Report *VA Generic Orderable Item Report *Create Pharmacy Orderable Items *Manually Match Dispense Drugs *Orderable Item Matching Status CMOP Mark/Unmark (Single drug) Locked with PSXCMOPMGR Drug Enter/Edit IMPORTANT: Once Pharmacy Data Management is installed, the Outpatient Drug Enter/Edit and the Inpatient Medications Dispense Drug Fields options will be disabled and the PDM Drug Enter/Edit option should be used. Drug Interaction Management... Enter/Edit Local Drug Interaction Edit Drug Interaction Severity Electrolyte File (IV) Lookup into Dispense Drug File Med. Route/Instructions Table Maintenance Medication Instruction File Add/Edit Orderable Item Management... Edit Orderable Items Dispense Drug/Orderable Item Maintenance Additive/Solutions, Orderable Items Orderable Item Report *Primary Drug Edit Pharmacy System Parameters Edit Standard Schedule Edit * These items are for pre-release only and will be deleted with the installation Outpatient Pharmacy V. 7.0 and Inpatient Medications V. 5.0. The PDM menu up to and including the release of PSS*1*87 appears below. PSS*1*87 was the last patch to affect a change to the PDM menu. Dosages ... Auto Create Dosages Dosage Form File Enter/Edit Enter/Edit Dosages Most Common Dosages Report Noun/Dosage Form Report Review Dosages Report Drug Enter/Edit Drug Interaction Management ... Enter/Edit Local Drug Interaction Report of Locally Entered Interactions Electrolyte File (IV) Lookup into Dispense Drug File Medication Instruction File Add/Edit Medication Route File Enter/Edit Orderable Item Management ... Edit Orderable Items Dispense Drug/Orderable Item Maintenance Orderable Item/Dosages Report Patient Instructions Report Orderable Item Report Formulary Information Report Drug Text Enter/Edit Drug Text File Report Pharmacy System Parameters Edit Standard Schedule Edit Synonym Enter/Edit Other Language Translation Setup Controlled Substances/PKI Reports DEA Spec Hdlg & CS Fed Sch Discrepancy Controlled Substances Not Matched to NDF CS (DRUGS) Inconsistent with DEA Spec Hdlg CS (Ord. Item) Inconsistent with DEA Spec Hdlg Send Entire Drug File to External Interface MK CMOP Mark/Unmark (Single drug)  Warning Builder Warning Mapping  Locked: PSXCMOPMGR Without the PSXCMOPMGR key XE "PSXCMOPMGR key" , the CMOP Mark/Unmark (Single drug) option will not appear on your menu. Other Language Translation Setup [PSS OTHER LANGUAGE SETUP] option is a stand-alone option that must be assigned to the person(s) responsible for maintaining it. Security Keys The following keys are assigned through the individual packages. PDM does not export any of these keys. Package Keys Outpatient Pharmacy PSORPH Inpatient Medications PSJU MGR Inpatient Medications PSJI MGR Automatic Replenishment/Ward Stock PSGWMGR Drug Accountability/Inventory Interface PSAMGR Controlled Substances PSDMGR National Drug File PSNMGR Consolidated Mail Outpatient Pharmacy PSXCMOPMGR (This page included for two-sided copying.) File Security Information about all files, including these, can be obtained by using the VA FileMan to generate a list of file attributes. PDM Files File Numbers File Names DDRD WR DEL LAYGO50 DRUG @50.4 DRUG ELECTROLYTES @50.606 DOSAGE FORM @ @ @ @50.7 PHARMACY ORDERABLE ITEM @51 MEDICATION INSTRUCTION @51.1 ADMINISTRATION SCHEDULE @51.2 MEDICATION ROUTES @51.5 ORDER UNIT 51.7 DRUG TEXT @52.6 IV ADDITIVES @52.7 IV SOLUTIONS @54 RX CONSULT 55 PHARMACY PATIENT (Partial DD) @ P59.7 PHARMACY SYSTEM ^ ^ ^ ^ Non-PDM Files File NumbersFile NamesDDRD WRDELLAYGO200 NEW PERSON (Partial DD) # # # # #9009032.3 APSP INTERVENTION TYPE 9009032.4 APSP INTERVENTION 9009032.5 APSP INTERVENTION RECOMMENDATION  Please refer to the "Sending Security Codes." section of the Kernel V. 8.0 Systems Manual for more information concerning installation of security codes. (This page included for two-sided copying.) References There are no regulations or directives related to the Pharmacy Data Management package. Additional manuals related to the Pharmacy Data Management package can be found at the VistA Documentation Library (VDL) on the Internet at:  HYPERLINK "http://www.va.gov/vdl/" http://www.va.gov/vdl/. (This page included for two-sided copying.) Glossary Administration Schedule File The ADMINISTRATION SCHEDULE file (#51.1) contains administration schedule names and standard dosage administration times. The name is a common abbreviation for an administration schedule (e.g., QID, Q4H, PRN). The administration time is entered in military time. CPRS A VistA computer software package called Computerized Patient Record System. CPRS is an application in VistA that allows the user to enter all necessary orders for a patient in different packages from a single application. Dispense Drug The Dispense Drug is pulled from DRUG file (#50) and usually has the strength attached to it (e.g., Acetaminophen 325 mg). Usually, the name alone without a strength attached is the Pharmacy Orderable Item name. Dosage Form File The DOSAGE FORM file (#50.606) contains all dosage forms and associated data that are used by Pharmacy packages and CPRS. The dosage form is used in SIG construction, default values and in the determination of the type of each dosage created for each application. Drug Electrolytes File The DRUG ELECTROLYTES file (#50.4) contains the names of anions/cations, and their cations and concentration units. Drug File The DRUG file (#50) holds the information related to each drug that can be used to fill a prescription or medication order. It is pointed to from several other files and should be handled carefully, usually only by special individuals in the Pharmacy Service. Entries are not typically deleted, but rather made inactive by entering an inactive date. Drug Interaction File The DRUG INTERACTION file (#56) is used to store DRUG-DRUG interactions. The file is sent out with data pre-populated. The pre-populated data cannot be deleted, data can only be added, or the severity of the national data can be elevated locally. Drug Text File The DRUG TEXT file (#51.7) stores rapidly changing drug restrictions, guidelines, and protocols to help assure medications are being used according to defined specifications. IV Additives File The IV ADDITIVES file (#52.6) contains drugs that are used as Additives in the IV room. Data entered includes drug generic name, print name, drug information, synonym(s), dispensing units, cost per unit, days for IV order, usual IV schedule, administration times, electrolytes, and quick code information. IV Solutions File The IV SOLUTIONS file (#52.7) contains drugs that are used as primary solutions in the IV room. The solution must already exist in the Drug file (#50) to be selected. Data in this file includes: drug generic name, print name, status, drug information, synonym(s), volume, and electrolytes. Local Possible Dosages Local Possible Dosages are free text dosages that are associated with drugs that do not meet all of the criteria for Possible Dosages. Medication Instruction File The MEDICATION INSTRUCTION file (#51) is used by Unit Dose and Outpatient Pharmacy. It contains the medication instruction name, expansion and intended use. Medication Routes File The MEDICATION ROUTES file (#51.2) contains medication route names. The user can enter an abbreviation for each route to be used at their site. The abbreviation will most likely be the Latin abbreviation for the term. Medication Routes/Abbreviations The Medication RouteS file (#51.2) contains the medication routes and abbreviations, which are selected by each Department of Veterans Affairs Medical Centers (VAMC). The abbreviation cannot be longer than five characters to fit on labels and the Medical Administration Record (MAR). The user can add new routes and abbreviations as appropriate. National Drug File The National Drug File provides standardization of the local drug files in all VA medical facilities. Standardization includes the adoption of new drug nomenclature and drug classification and links the local drug file entries to data in the National Drug File. For drugs approved by the Food and Drug Administration (FDA), VA medical facilities have access to information concerning dosage form, strength and unit; package size and type; manufacturers trade name; and National Drug Code (NDC). The NDF software lays the foundation for sharing prescription information among medical facilities. Non-Formulary Drugs Drugs that are not available for use by all providers. Orderable Item An Orderable Item is pulled from the PHARMACY ORDERABLE ITEM file (#50.7) and usually has no strength attached to it (e.g., Acetaminophen). The name, with a strength attached, is the Dispense Drug name (e.g., Acetaminophen 325mg). Orderable Item File The ORDERABLE ITEM file (#101.43) is a CPRS file that provides the Orderable Items for selection within CPRS. Pharmacy Orderable Items are a subset of this file. Pending Order A pending order is one that has been entered by a provider through CPRS without Pharmacy finishing the order. Once Pharmacy has finished (and verified for Unit Dose only) the order, it will become active. Pharmacy Orderable Item The Pharmacy Orderable Item is used through CPRS to order Inpatient Medications and Outpatient Pharmacy prescriptions. Pharmacy Orderable Item File The PHARMACY ORDERABLE ITEM file (#50.7) contains the Order Entry name for items that can be ordered in the Inpatient Medications and Outpatient Pharmacy packages. Possible Dosages Dosages that have a numeric dosage and numeric Dispense Units Per Dose appropriate for administration. For a drug to have possible dosages, it must be a single ingredient product that is matched to VA PRODUCT file (#50.68). The VA PRODUCT file (#50.68) entry must have a numeric strength and the dosage form/unit combination must be such that a numeric strength combined with the unit can be an appropriate dosage selection. Prompt A point at which the system questions the user and waits for a response. Standard Schedule Standard medication administration schedules are stored in the Administration Schedule file (#51.1). Units Per Dose The Units Per Dose is the number of Units (tablets, capsules, etc.) to be dispensed as a dose for an order. Fractional numbers will be accepted. VA Drug Class Code A drug classification system used by VA that separates drugs into different categories based upon their characteristics. Some cost reports can be run for VA Drug Class Codes. VA Product File The VA PRODUCT file (#50.68) contains a list of available drug products.     User Manual  PAGE iv Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0  PAGE iii Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0  PAGE i Technical Manual/Security Guide  PAGE 2 Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0  PAGE 1 Technical Manual/Security Guide  PAGE 10 Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0  PAGE 31 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0  PAGE 3 Technical Manual/Security Guide 24b Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0 24a Technical Manual/Security Guide  PAGE 32 Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide PAGE 25 September 1997 Pharmacy Data Management V. 1.0 Technical Manual/Security Guide 32 PAGE b Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 2001 Pharmacy Data Management V. 1.0 32 PAGE c Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0 32 PAGE a Technical Manual/Security Guide 32d Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0 32c Technical Manual/Security Guide 32f Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0 32e Technical Manual/Security Guide 32h Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0 32g Technical Manual/Security Guide  PAGE 52 Pharmacy Data Management V. 1.0 September 1997 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0  PAGE 51 Technical Manual/Security Guide September 1997 Pharmacy Data Management V. 1.0  PAGE 33 Technical Manual/Security Guide  EMBED Word.Picture.8  The Other Language Translation Setup [PSS OTHER LANGUAGE SETUP] option is a stand-alone option that must be assigned to the person(s) responsible for maintaining it. When using the CMOP Mark/Unmark (Single drug) [PSSXX MARK] option to mark a drug for CMOP the user must update the cost information in the DRUG file (#50) to ensure the cost data for each prescription fill will be correct. AMW[\]fmqrsuy|Ǫ|o_TIThhOJQJhhnOJQJhhnCJOJQJ\aJh9CJOJQJ\aJh;CJOJQJ\aJh(hnCJOJQJ\aJ hSs5\hhn5\hhnOJQJ\aJhhn; hhnhhn5CJ0OJQJhhn5OJQJ$jhhnCJUmHnHujhhsU@AM\]stuvxyz{|}~  ? 87$8$H$$1$ > 87$8$H$>$a$Ԁ{![ \ a o | $$Ifa$ sdgd}0xx$d%d&d'd-D M NOPQ$a$$a$ @ 87$8$H$[ \ ` a xlxlhdh]YUQUM]h]Mhh36hxh9] hwh|mhh|mhhn5>*CJhhn5CJhh}CJaJ+hhn5B*CJOJQJ\^Jph+hhn5B*CJ$OJQJ\^Jph hhnhhnOJQJ\hhn5OJQJhh}OJQJhhn\'jhhnCJU\mHnHu 1( $Ifgd+vkd$$IfTl4\ $$88  (0$4 lap(T - . 4 A8 $Ifgd+vkd$$IfTl\ $$880$4 laT $Ifgdw $$Ifa$gd+v $If^gd+v   - .  0  Y-twwp hh,whhn6hhn6] hhnh\ h\ h\ h[,h0W hhfhA hhUD hUhq~h# hUhUD hhK hwhGn hwhw hwhK hh|mh36 hwh36h|m hh,4 > H A8 $Ifgd+vkd$$IfTl\ $$880$4 laT $Ifgdw $$Ifa$gd+v $If^gd+v  p A8 $Ifgd+vkd$$IfTl\ $$880$4 laT $IfgdUD $$Ifa$gd+v $If^gd+v  / 0 6 A8 $IfgdpkdJ$$IfTl\ $$880$4 laT $Ifgd+v $$Ifa$gd+v $If^gd+v6 @ J A8 $Ifgd+vkd $$IfTl\ $$880$4 laT $Ifgdp $$Ifa$gdp $If^gdp nA;$Ifkd$$IfTl\ $$880$4 laT $Ifgd+v $$Ifa$gd+v $If^gd+vJkd$$IfTl\ $$880$4 laT$If $$Ifa$ $If^TJ $If^kdR$$IfTl\ $$880$4 laT$If $$Ifa$ .7c]SJ] $$Ifa$ $If^$Ifkd$$IfTl\ $$880$4 laTLMbPebcjmnqthhn;\^JhhnjhhnU hUNShn hshnhhnB*phhhnCJhKhUNShhnB* phhhfB* phhhf6 hhf hh\ hbg hhnhhn6]#$cWMD>$If $$Ifa$ $If^ $$$Ifgd+Akd$$IfTl\ $$880$4 laTc]SJ] $$Ifa$ $If^$Ifkd$$IfTl\ $$880$4 laT]WJJAW $$Ifa$ $If^gd+v$IfkdZ$$IfTl4\ $$880$4 laf4yt\T"c]SJ] $$Ifa$ $If^$Ifkd($$IfTl\ $$880$4 laTcc]QH] $$Ifa$ $$Ifa$gdK$Ifkd$$IfTl\ $$880$4 laTcdjnr`ZNDZ h$If^h $$Ifa$gdK$Ifkd$$IfTl4\ $$880$4 laf4TQca\WRPJ $ ugdZgds$a$kdt$$IfTl\ $$880$4 laT !"#/01KLMNOPQRSop⼳{hZQZh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu h9]aJj h9]Ujh9]U h9]'j6 h9]h9]>*B*Uphh9]hih9]0J jhih9]0J U1hhnCJOJQJ\]^JaJmH nH u:jhhnCJOJQJU\]^JaJmH nH upqrźӆ}cźR j"h9]UmHnHu2j*"h9]h9]>*B*UmHnHphuh9]mHnHu&h9]5OJQJ\]^JmHnHu j!h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j0!h9]h9]>*B*UmHnHphuQC:<BFI E!!!8" $  $ #$%&^_`z{|}~ԱԦlԦ[ j$h9]UmHnHu2j$h9]h9]>*B*UmHnHphu j#h9]UmHnHujh9]UmHnHuh9]mHnHu2j$#h9]h9]>*B*UmHnHphuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHuh9]\mHnHu# !"<=>@ABCDEabcdwxyλ谡k谡Z j&h9]UmHnHu2j&h9]h9]>*B*UmHnHphuh9]\mHnHu j%h9]UmHnHujh9]UmHnHuh9]mHnHu$jhih9]0J UmHnHu2j%h9]h9]>*B*UmHnHphuhih9]0J mHnHuh9]mHnHu"345789:;<XYźӏņlź[ӏņ j(h9]UmHnHu2j(h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu j'h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j 'h9]h9]>*B*UmHnHphu YZ[źӄ{aźPӄ jw*h9]UmHnHu2j)h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu j})h9]UmHnHujh9]UmHnHuhN'XmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j)h9]h9]>*B*UmHnHphu !"#ghiλ谡k谡Z jk,h9]UmHnHu2j+h9]h9]>*B*UmHnHphuh9]\mHnHu jq+h9]UmHnHujh9]UmHnHuh9]mHnHu$jhih9]0J UmHnHu2j*h9]h9]>*B*UmHnHphuhih9]0J mHnHuh9]mHnHu"5679:;<=>Z[\]opqźӏņlź[ӏņ j_.h9]UmHnHu2j-h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu je-h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j,h9]h9]>*B*UmHnHphu   !;<=?@ABCD`aźӏņlź[ӏņ jS0h9]UmHnHu2j/h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu jY/h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j.h9]h9]>*B*UmHnHphu abcwxyźӏņlź[ӏņ jG2h9]UmHnHu2j1h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu jM1h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j0h9]h9]>*B*UmHnHphu #$%?@ACDEFGHdefgz{|źӆ}cźR j;4h9]UmHnHu2j3h9]h9]>*B*UmHnHphuh9]mHnHu&h9]5OJQJ\]^JmHnHu jA3h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j2h9]h9]>*B*UmHnHphu    & ' ( B C D F G H I J K ԱԦlԦ[ j/6h9]UmHnHu2j5h9]h9]>*B*UmHnHphu j55h9]UmHnHujh9]UmHnHuh9]mHnHu2j4h9]h9]>*B*UmHnHphuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHuh9]\mHnHu#K g h i j { | } !!λ谡k谡Z j#8h9]UmHnHu2j7h9]h9]>*B*UmHnHphuh9]\mHnHu j)7h9]UmHnHujh9]UmHnHuh9]mHnHu$jhih9]0J UmHnHu2j6h9]h9]>*B*UmHnHphuhih9]0J mHnHuh9]mHnHu"!!!"!#!$!>!?!@!B!C!D!E!F!G!c!d!e!f!{!|!}!!!!!!!!!!!!źӏņlź[ӏņ j:h9]UmHnHu2j9h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu j9h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j8h9]h9]>*B*UmHnHphu !!!!!!!!!!!!!!!"""""""1"2"3"5"6"7"8"9":"V"W"źӏņlź[ӏņ j <h9]UmHnHu2j;h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu j;h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j:h9]h9]>*B*UmHnHphu W"X"Y"f"g"h"""""""""""""""""""""""""źӏņlź[ӏNjhih9]0J U j=h9]UmHnHu2j=h9]h9]>*B*UmHnHphuh9]mHnHuh9]\mHnHu j=h9]UmHnHujh9]UmHnHuh9]mHnHuhih9]0J mHnHu$jhih9]0J UmHnHu2j<h9]h9]>*B*UmHnHphu8"""##%#&#T#U#V#W#y#z#2%3%&&6'7'X''' h h^h & F   !  gdZ$a$$((1$7$8$H$a$gdJ! $  $ """"""###### #!#"###$#%#&#'#(#T#U#c#d#͸ҲrgXrF"jhhn5CJU\hJ!6B*CJ]aJphhhnB*phhhnCJ$OJQJ^Jhhn;\^J hhn:jhhnCJOJQJU\]^JaJmH nH u h9]aJj>h9]Ujh9]U h9]jhih9]0J U'j|>h9]h9]>*B*Uphh9]hih9]0J d#w#x#1%2%3%W&\&]&&&&&&&&&5'6'e't'i(q(&)-)))))))))%*&*c*d**ǿǿكyٰٰٰٰٰlajvDhhnUjv?hhnEHUhhn5\hhn6hhn;\hhn\jhhn;U\hhn5 hh,whhn\hhn;\hhn; hhn"jhhn5CJU\hhn5CJ\%''((E(r(s(%)&)~))))$*%*^*c** & F  h`h & F   h   ^   & F   h h^h & F  h`h & F**`+a+b+++++++9-@-|-}----1 2!2"22222333 3,3-32333L4Y4e5x555휍vffhhnOJQJ]^JaJhhnCJaJhhn5CJ$\ jhhn5CJ$\hhnaJhhn5\hJ!6B*CJ]aJph"hhn5CJ$OJQJ\^Jhhn5hhnCJ8 jhhnCJH hhnjZYhhnU(*`+++--i-j-{-|------y1{1$a$$((1$7$8$H$a$gdJ!( ! & F   h  & F  # h # & F |^`|#  ^`{12 222233 3,3-3^kd>n$$Ifl44FT6%0t%6    4 laf4$If$If ! -313237333333K4Wkdn$$Ifl4\T6%<0t%64 laf4$If$If K4L4P4Q4Y4d5c]]]]$Ifkdo$$Ifl4\T6%<0t%64 laf4d5e5i5j5x55c]]]]$Ifkdp$$Ifl4\T6%<0t%64 laf455555<6c]]]]$Ifkd_q$$Ifl4\T6%<0t%64 laf4<6=6A6B6L66c]]]]$Ifkd,r$$Ifl4\T6%<0t%64 laf45=6L66 7x7778U8k88899 9 999!9E:F:_:;;;;;;<=>=?=`=a=b=c=d={=?#?-?.?/?O?AAABBBBCChDﲦhhnB*phhhn6]aJhhnaJhhn5CJ$\hhnCJaJhhn5CJ\aJ jhhn5CJ$\hhn5\ hhn56666 7w7c]]]]$Ifkdr$$Ifl4\T6%<0t%64 laf4w7x7|7}777c]]]]$Ifkds$$Ifl4\T6%<0t%64 laf477778T8c]]]]$Ifkdt$$Ifl4\T6%<0t%64 laf4T8U8W8X8k88c]]]]$Ifkd`u$$Ifl4\T6%<0t%64 laf4888889c]]]]$Ifkd-v$$Ifl4\T6%<0t%64 laf499 9 9 9"9D:c]]]]R $7$8$H$If$Ifkdv$$Ifl4\T6%<0t%64 laf4D:E:H:I:_:;;c]]]]]$Ifkdw$$Ifl4\T6%<0t%64 laf4;;;;;<===c]]]R] $7$8$H$If$Ifkdx$$Ifl4\T6%<0t%64 laf4==>=A=B=`=a=c]]]R $7$8$H$If$Ifkday$$Ifl4\T6$<0t%6 4 laf4a=b=c=h={=,?-?c]]]RR $7$8$H$If$Ifkd.z$$Ifl4\T6$<0t%6 4 laf4-?.?1?2?3?4?5?6?7?8?9?c]]]]]]]]]$Ifkdz$$Ifl4\T6$<0t%6 4 laf4 9?:?O?AAAAABRkd{$$Ifl4\T6$<0t%6 4 laf4 $7$8$H$If$IfBBBBBCc]]]R $7$8$H$If$Ifkd|$$Ifl4\T6$<0t%6 4 laf4CCCDDhDkDlDoDqDc^\ZZZTZOgdZ $a$kdb}$$Ifl4\T6$<0t%6 4 laf4 hDiDlDmDnDqDrDEEEEF.F6FSFlFsFFFFGGGG'H1H2HGHHHHPNWNoNNNNOOOOTTTT۶⭡rjݒhhPEHUjhhPEHUhhnEHhhn5\aJhhn6]aJhhnaJhhnCJOJQJjhhPEHUj/~hhnU hhnhhnCJaJ$jhhnCJUmHnHu,qDDDEE.F/F6FGG"H#HHHNIOIKK#$d %d &d 'd N O P Q ^ gdZ+`$d %d &d 'd N O P Q ^``K M"MLNNNPNWNOOORRTTTqUrU}U~UUUUU d !$a$#$d %d &d 'd N O P Q TqUrU~UUUUUUUUUU VXXXXXXYYYY5YZZJZ]ZZZ[[̸̸̸}}̸̸̸}nbWhhnCJaJhhn6]aJhJ!6B*CJ]aJph hhnCJOJQJ^JaJ)hhn5>*CJOJQJ\^JaJ)hhn5>*CJOJQJ\^JaJ&hhn5CJOJQJ\^JaJ&hhn5CJOJQJ\^JaJ hhnhhn5OJQJ\^JhhnaJ U VV)V*VQVRVVVVVVV2W3WqWrWWWWWWWWXXCX (d ! d ! dCXDXyXzXXXXXXXXXXY5Y6YeYfYYYYY ZZZZ d! d  ! d d !ZZJZ]Z^Z[[<[=[s[[[\'\F\f\\\\\]<]=]Y]|]] -D M $a$gdJ!$((1$7$8$H$a$gdJ!['[:[n[o[#\$\7\<\a\e\{\\\\\\\]4]<]t]{]]]]]^^^_ _!_"_6_﷫ld] hhnhhn;-hhn5;CJOJQJaJmH nH u0hhn5;CJOJQJ\aJmH nH uhJ!6B*CJ]aJphhhn;\^J"hhn5CJ$OJQJ\^J#hhn>*CJOJQJ^JaJ&hhn5CJOJQJ\^JaJ hhnCJOJQJ^JaJ"]]]] ^^f^g^|^^^^^_ _!_6_7___ `-`.``` -D M $a$$((1$7$8$H$a$gdJ! -D M 6__-`.```cczeeff+gKgrjj,kFknnnnnoooooootpp7qqrrrssssttuuyuxxx@yByyy{|||g}"hhn6CJOJQJ]^J$hhnCJOJQJ^JmH sH "hhn5CJOJQJ\^J hhnCJOJQJ^JaJ hhnCJOJQJ^JaJhhnCJOJQJ^JhhnaJ8`` a)aIakaaaaaab*b8bYbgbbbbbc c2cIccccd &-D M  -D M dde_eeefffgKgMgiiijjjjUjjjkknn=nn &-D M  -D M nnnoo8o|ooooop`ppp6q7qZqqqqrr$rfrrr &-D M  -D M  -D M rssss'thtjtktlttttuuu!v"vPvQv(w)wVwwwww -D M  &-D M  -D M wxx4xvxxx@yByoyyyyt{u{{{||U|V|`||||}e} -D M  &-D M  -D M e}g}}}~Y~Z~~~ˁ́4oq$&NV~ -D M  &-D M  -D M g}}0~Y~́4KoVl~ņ@` 8;<ËċNvwޯ횉mWm*hhn5CJOJQJ\^JmHsH$hhnCJOJQJ^JmHsHhhnaJ hhnCJOJQJ^JaJ(hhnCJOJQJ^JaJmH sH hhnCJOJQJ^JaJhbgCJOJQJ^J"hhn5CJOJQJ\^JhhnCJOJQJ^J$hhnCJOJQJ^JmH sH "Ćņ3`a  89:;Ëċ7` -D M  &-D M  -D M `όNwɍDm:Zŏ#6] d-D M  !d-D M  -D M # ۔=Y UVDJLOƙE^ϛXwÞ9Yסpq'jy_w(̶̧$hhnCJOJQJ^JmH sH hbgCJOJQJ^Jh<]hnCJOJQJ^J*hhn5CJOJQJ\^JmHsH$hhnCJOJQJ^JmHsH"hhn5CJOJQJ\^JhhnCJOJQJ^J5]ސ0Y 2Yђ7[Fo۔ -D M  d-D M  -D M ۔=NǕ=Yx,UٗKbvD -D M DƙܙE^)>nϛ`؜Xw += -D M =hÞޞPßӟ9YϠ*;rס 0}5 -D M 5RsCפ'Qx)jyЦ_ dx-D M  d-D M  -D M  -D M _5uƨ(T{ʩ+lҪ*T dx-D M  d-D M  -D M ɩʩЩl2,PaòвmζԸȹɹʹ]кѺȼI«嫇wjhhnB*aJphhhn6B*]aJphhhnB*phhhn5CJOJQJ^JhhnaJ-hhn;CJOJQJ\aJmH nH u hhnCJOJQJ^JaJ"hhn5CJOJQJ\^JhhnCJOJQJ^JhbgCJOJQJ^J(ZЬ2[ɭ_,Pw7 d-D M  dx-D M  -D M  !-D M ΰڰ aʱEWòвm|3Z d-D M  -D M ,mҵHXζ.v 7P|Ը^ !-D M  -D M ɹʹ]ǺEԻIJֽ$-D7$8$H$M L7$8$H$ -DM  -D M IJʿB8y !%QT\]^ϼ奘}}ng^UOKh5 hq~aJhhnaJhhnPJ h(hnhJ!6B*CJ]aJph hhnCJOJQJ^JaJhhn5\hhnCJOJQJhhn5CJOJQJ\ hhn%hhnB*CJOJQJ^Jph+hhn5B*CJOJQJ\^JphhhnCJOJQJ^JhhnB*ph$pǾʿB:-D 7$8$H$M N -D M  -DM -D7$8$H$M 8y2zC!"#$Q$((1$7$8$H$a$gdJ! -D M N -DM -D 7$8$H$M QRST]^ k$IfgdBy((1$7$8$H$gd57$8$H$gdZ$a$gdJ!% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy )% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy Ht|}!)"qynuF^xxnxaVajեhhnUhhnaJmHsHhhn]aJhhnaJ"hhn5CJ$OJQJ\^JhJ!6B*CJ]aJphh; hhn h?L h5CJOJQJ^JaJh?L h5\h?L h5aJh?L h5PJaJh?L h5^JaJh?L h5^Jh?L h5mH sH h?L h5!)07?HQ k$IfgdByQRZc% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytByckt} k$IfgdBy% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd%$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy )1: k$IfgdBy:;DM% k$IfgdBykd5$$Ifl֞v gXI:," t0644 laytByMV_gpy k$IfgdByyz% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykdE$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd͜$$Ifl֞v gXI:," t0644 laytBy!( k$IfgdBy()08% k$IfgdBykdU$$Ifl֞v gXI:," t0644 laytBy8?HQY` k$IfgdBy`aho% k$IfgdBykdݝ$$Ifl֞v gXI:," t0644 laytByov~ k$IfgdBy% k$IfgdBykde$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy  % k$IfgdBykdu$$Ifl֞v gXI:," t0644 laytBy )2:CL k$IfgdByLMV^% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy^fnv~ k$IfgdBy% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd $$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy"+2: k$IfgdBy:;DM% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytByMV_hpy k$IfgdByyz% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd-$$Ifl֞v gXI:," t0644 laytBy k$IfgdBy% k$IfgdBykd$$Ifl֞v gXI:," t0644 laytBy %. k$IfgdBy./8A% k$IfgdBykd=$$Ifl֞v gXI:," t0644 laytByAHPX`h k$IfgdByhiqy% k$IfgdBykdŤ$$Ifl֞v gXI:," t0644 laytByy k$IfgdBy% gd5kdM$$Ifl֞v gXI:," t0644 laytBymnouv78 hgdZ$a$$((1$7$8$H$a$gd;((1$7$8$H$gd58Yxy*.@XYy/JKk h^ hkxy;<Rop25Hbc h^ hYZ[\])*MNtu ^^X^X h 4Xde)*N')*fǽݵynYNhhnB*ph)jhhnB*UmHnHphuhhnCJaJ$jhhnEHUmHnHuhhnCJaJ h>hnhhnmH sH hhn6]aJhhn6hhn\hhnjhhnU\hhn\ hhnjhhUhhnaJu 56no%&PQ-.vX^X^vw#$JKpq')Kfg hp@ .X^X !X^X^ ^`fg01{|<=>žؓ†{se]S]ehhn\hhnjhhnU\hhn\jhh$S6UhhnB*CJphjhh$S6U jhhnUmHnHu$jhhnCJUmHnHuhhnB*phhhnCJaJ hhnhhn6]hhnaJhhnB*CJph 01]{|>?Oefv^ 7$8$H$^X^X"#$%9QRqƿpe[MBMBhhnB*phhhn5B*\phhhn5\hhnB*ph"hhn5CJ$OJQJ\^JhJ!6B*CJ]aJph"hhn5CJOJQJ\^Jhhn6]hhnCJhhnaJ hhnj hh$S6EHUhhn5CJ#hhnOJPJQJ\^JaJhhn6hhn\"#$$a$$ $ d]^a$$((1$7$8$H$a$gdJ!2 $ d$d %d &d 'd  N O P Q  ]^D Pd[$\$ Pd<=>hi(4$If 45kd5$$Ifl44Prb&L2 ) 20&64 laf4p259;=@PQRTYOkd$$Ifl4rb&L2 )0&64 laf4$If Y\pqrt}Okdm$$Ifl4rb&L2 )0&64 laf4$Ifqr127;VW\`{|PQlm?@EI NO|}JK89>G`ahhnB*phhhn5B*\phXUOOOOO$IfkdJ$$Ifl4rb&L2 )0&64 laf4UOOOOO$Ifkd'$$Ifl4rb&L2 )0&64 laf4UOOOOO$Ifkd$$Ifl4rb&L2 )0&64 laf4UOOOOO$Ifkd$$Ifl4rb&L2 )0&64 laf40UOOOOO$Ifkd$$Ifl4rb&L2 )0&64 laf40123456SMMMMM$Ifkd$$Ifl4rb&L2 )0&64 laf467;=EJUSMMMMM$Ifkd|$$Ifl4rb&L2 )0&64 laf4UVWXYZ[SMMMMM$Ifkd]$$Ifl4rb&L2 )0&64 laf4[\`bjozSMMMMM$Ifkd> $$Ifl4rb&L2 )0&64 laf4z{|~UOOOOO$Ifkd $$Ifl4rb&L2 )0&64 laf4XRRRRR$Ifkd $$Iflrb&L2 )0&64 laXRRRRR$Ifkd $$Iflrb&L2 )0&64 laXRRRRR$Ifkd $$Iflrb&L2 )0&64 laXRRRRR$Ifkd $$Iflrb&L2 )0&64 la69OXRRRRR$IfkdX$$Iflrb&L2 )0&64 laOPQS[^kXRRRRR$Ifkd/$$Iflrb&L2 )0&64 laklmoXRRRRR$Ifkd$$Iflrb&L2 )0&64 laUOOOOO$Ifkd$$Ifl4rb&L2 )0&64 laf4XRRRRR$Ifkd$$Iflrb&L2 )0&64 laXRRRRR$Ifkd$$Iflrb&L2 )0&64 la/2>XRRRRR$Ifkdh$$Iflrb&L2 )0&64 la>?@ABCDXRRRRR$Ifkd?$$Iflrb&L2 )0&64 laDEIKcfXRRRRR$Ifkd$$Iflrb&L2 )0&64 laXRRRRR$Ifkd$$Iflrb&L2 )0&64 la XRRRRR$Ifkd$$Iflrb&L2 )0&64 la ,/MXRRRRR$Ifkd$$Iflrb&L2 )0&64 laMNOQ_b{VPPPPP$Ifkdr$$Ifl_rb&L2 )0&64 la{|}XRRRRR$IfkdM$$Iflrb&L2 )0&64 laXRRRRR$Ifkd$$$Iflrb&L2 )0&64 laXRRRRR$Ifkd$$Iflrb&L2 )0&64 laXRRRRR$Ifkd$$Iflrb&L2 )0&64 laXRRRRR$Ifkd$$Iflrb&L2 )0&64 la-0IXRRRRR$Ifkd$$Iflrb&L2 )0&64 laIJKM]`XRRRRR$IfkdW$$Iflrb&L2 )0&64 laVPPPPP$Ifkd.$$Iflcrb&L2 )0&64 laVPPPPP$Ifkd $$Iflorb&L2 )0&64 laXRRRRLI$If$Ifkd $$Iflrb&L2 )0&64 laXRRRRR$Ifkd!$$Iflrb&L2 )0&64 la367VPPPPP$Ifkd"$$IflTrb&L2 )0&64 la789:;<=XRRRRR$Ifkdm#$$Iflrb&L2 )0&64 la=>GIQT_XRRRRR$IfkdD$$$Iflrb&L2 )0&64 la_`acloXRRRRR$Ifkd%$$Iflrb&L2 )0&64 laXRRRRR$Ifkd%$$Iflrb&L2 )0&64 laXVPPPPP$Ifkd&$$Iflrb&L2 )0&64 la;<XY~ <=QRcdvw|#$67<=LMjkyz wzUthhn5hhn5\hhnB*H*phhhnB*phhhn5B*\ph hhnLkd'$$Ifl44Prb&L2 ) 20&64 laf4p2Rkd($$Iflrb&L2 )0&64 la$If 1:;<>SVWRkd)$$Iflrb&L2 )0&64 la$If WXY[y|}XRRRRR$Ifkd*$$Iflrb&L2 )0&64 la}~XRRRRR$Ifkd+$$Iflrb&L2 )0&64 laXRRRRR$IfkdW,$$Iflrb&L2 )0&64 laXRRRRR$Ifkd.-$$Iflrb&L2 )0&64 laXRRRRR$Ifkd.$$Iflrb&L2 )0&64 la XRRRRR$Ifkd.$$Iflrb&L2 )0&64 la #&;XRRRRR$Ifkd/$$Iflrb&L2 )0&64 la;<=?LOPXRRRRR$Ifkd0$$Iflrb&L2 )0&64 laPQRT^abXRRRRR$Ifkda1$$Iflrb&L2 )0&64 labcdfqtuXRRRRR$Ifkd82$$Iflrb&L2 )0&64 lauvwxyz{XRRRRR$Ifkd3$$Iflrb&L2 )0&64 la{|XRRRRR$Ifkd3$$Iflrb&L2 )0&64 laXRRRRR$Ifkd4$$Iflrb&L2 )0&64 laXRRRRR$Ifkd5$$Iflrb&L2 )0&64 laXRRRRR$Ifkdk6$$Iflrb&L2 )0&64 laXRRRRR$IfkdB7$$Iflrb&L2 )0&64 la "XRRRRR$Ifkd8$$Iflrb&L2 )0&64 la"#$&7:;XRRRRR$Ifkd8$$Iflrb&L2 )0&64 la;<=?MPiVPPPPP$Ifkd9$$Ifldrb&L2 )0&64 laijkmz}VPPPPP$Ifkd:$$Ifldrb&L2 )0&64 laVPPPPP$Ifkd};$$Ifldrb&L2 )0&64 laVPPPPP$IfkdX<$$Ifldrb&L2 )0&64 laXRRRRG  !$If$Ifkd3=$$Iflrb&L2 )0&64 laXRRRRR$Ifkd >$$Iflrb&L2 )0&64 la CD|XVTVVVOOO & Fkd>$$Iflrb&L2 )0&64 la w=>cv 7$8$H$$a$ ^ ]^^h^h & Ft=>b  48<WY/%'=Ogt!GﰡhhnCJaJhhnCJhhn5CJaJhhnCJOJ QJ aJ hhnCJOJQJ^JaJhhn>*hhnCJhhnjhhnUhhn5hhn5\ hhn2 ;< +3 MPP$If M$PP$Ifa$ PP$If PP$If]$a$7$8$H$348:<?ABCSUVWY[^`abv{|}FfK V$IfFf[F $If $$Ifa$$If M V$If$IfFfA} FfSTFfO$If $If $$Ifa$ V$If 6CDEGKNPQVFf] $$Ifa$ V$IfFfX$If $If /567:FfkFff $If $$Ifa$ V$If$IfFfKb:<?AFGUWXY\^bdijuyz{~FftFfCp$If $If $$Ifa$ V$IfFfI~ $If $$Ifa$ V$IfFfy$If 3789;=@FfOFf $$Ifa$ V$If$IfFf@BCH\_`abcdefghijnpruwx}FfGFf V$IfFf$IfFf $$Ifa$Ff $If] V$If$If*+,.0356;FHIJLPSUVWiFf $If] V$IfFfM$IfFfFfE $If] V$If$IfFf 134579<>?@NFf= V$IfFf$If $If]NPQRTX[]^_l]Ff5Ff $If] V$IfFf$If &./037:<=>Vn $If] V$If$IfFf MPP$If M$PP$Ifa$ PP$If PP$If$a$nopswz|}~FfFf; $If] V$If$IfFf!"#&*-/01@TUVY\_abcxFf3 V$IfFf$If $If]xFf+Ff $If] V$IfFf$If/12369<>?@Ff{Ff$If $If] V$If@IMNORVY[\]bstux{~FfsFf $If] V$IfFf# $IfFfFf$If $If] V$If%'(),/2456=OPQTWZ\]^gtuFf*Ff& $If] V$IfFfk!$Ifuvy|Ff 4Ffc/ $If] V$If$If!Ff[= $If] V$IfFf8$If!"#&(+-./GIJKLMNOPQRSTXZ^FfSKFfF $If] V$If$IfFfBGIRSw y z   :         , t              ǾǾǾdž}Ǿyun hkhwIhwIhnhhn0J j`hhnUjhhnUhh,waJhhn6aJhhn6]aJhhnaJ hhnhhnB*phhhnCJhhn5\hhnCJhhnCJaJ+^acdeFfT V$IfFfO$If $If]KL  hh^hh^h]$a$Ff] $If] V$IfFfKY$If()ghqrC D    hh^h      x y z     9 :      M N $%gdkgdwI !$X^Xa$h^h hh^h  @AVvwx-D 7$8$H$M BI !gdwIgdwIgdkFObc  2;ABMN137@AVruMbtvɸ hshn&hhn5CJOJQJ\^JaJ hhnCJOJQJ^JaJhhnCJhhn6]aJhhnaJ hhn hwIhwI hUhwIhwI=0fuv~  !, ,t ^  -D M -D 7$8$H$M DZdk1-#.#)),,/Y/a0v055<<==Z?e?AAC-CMMMķķhhnB*CJphjahhPEHUhhn5\hJ!6B*CJ]aJphhhnaJmH sH h>hnaJhhn>*aJhhn5>*\aJhhnaJ hhnhhn5\^J14\]^_&Ddv  !, ,t ,4P^`P  !,b4 ,b4 ,b401jl  - , ,b4$ ,b4a$$((1$7$8$H$a$gdJ!-Mj!!! ",".""-#.#%%~&&&'d'f'()^ & F X ))))**,,///#/$/Y///0_0a000000@ ^@ @ ^@ ` @ ^@ `  !<`<^ & F^01111C5E5G5555566666 7&7B7\7^7?8A8 ^`h^h & F^^ p^p` @ ^@ `A8]9^9h9j9999:6:R:n:::;;G<I<<<====X?h^h & F ! ^` & F^X?Z?d?e?AAAAAAB[BBBCCICdCCCCC ^`&'$d %d &d 'd N O P Q ^^h^h & FCC"FFFFFGGGGH H>H@HIIIIIIkJJJJJJK ^`^& & FKKKKL.LJLfLLLLLMMMMMNN2O3O4O !N  N  N $a$$((1$7$8$H$a$gdJ!( ^`^MMNN2O4OKOLOyO|OOOOOQDRZRRRRRRRRR=SS T2T*CJ\aJhhnCJaJhhnCJaJhhnCJaJ hJ!6B*CJ]aJphhhn5>*\aJhhnaJ hhnhhn6B*]phhhn6B*]phhhn6]hhnB*EHph#___`.```a`b``````aa)a*a0a8a9aDaJaMa )$If])$If $If$a$$((1$7$8$H$a$gdJ! ^MaRaYaaabaaBkd$$IfP4֞8$^%<LX%4 Paf4 r$If]r$IfaaaaaaaQ7kd$$IflD%%%4 la7kdW$$IflD%%%4 la$If7kd$$IflD%%%4 laaabbbbLbQ7kdǘ$$IflD%%%4 la7kdk$$IflD%%%4 la$If7kd$$IflD%%%4 laLbMbNbObbbbQ7kdۙ$$IflD%%%4 la7kd$$IflD%%%4 la$If7kd#$$IflD%%%4 labbbbbbbQ7kd$$IflD%%%4 la7kd$$IflD%%%4 la$If7kd7$$IflD%%%4 labbbbc c!cQ7kd$$IflD%%%4 la7kd$$IflD%%%4 la$If7kdK$$IflD%%%4 la!c"cTcUcVcWccQ7kd$$IflD%%%4 la7kd$$IflD%%%4 la$If7kd_$$IflD%%%4 lacccccccQ7kd+$$IflD%%%4 la7kdϝ$$IflD%%%4 la$If7kds$$IflD%%%4 lacccccc-dQ7kd?$$IflD%%%4 la7kd$$IflD%%%4 la$If7kd$$IflD%%%4 la-d.d/d0d{d|d}dQ7kdS$$IflD%%%4 la7kd$$IflD%%%4 la$If7kd$$IflD%%%4 la}d~dddddddddddd r$If]r )$If])$If $If ^  7kd$$IflD%%%4 la badddddddddddddddeeeKfMfNfzfff6g;glgmgggggggøøøøøøﯢ扂{pbppjhhnUjhhnU hh,w hhnhJ!6B*CJ]aJphhhn5\jhh|FEHUhhnEHhhnCJaJhhn5>*CJ\aJ&hhn5CJOJQJ\^JaJhhnaJ hhnCJOJQJ^JaJ"ddeRL$Ifkd $$IfP4֞rW<! ^%%4 Paf4eeeeBeCeDeG= $If7kd$$Ifl(%d%%64 la  !$If7kd5$$Ifl(%d%%64 la$If7kd١$$Ifl(%d%%64 laDeEevewexeyeeQ7kd$$Ifl(%d%%64 la7kdI$$Ifl(%d%%64 la$If7kd$$Ifl(%d%%64 laeeeeeJfKfLfNfeee_Z$a$ ^#$d%d&d 'dNOP Q7kd]$$Ifl(%d%%64 la$If7kd$$Ifl(%d%%64 laNfzfffggggggggggiiiijjkkll x^x`$a$ ^7$8$H$$((1$7$8$H$a$gdJ!gggggggggggh h%hiiiiii}iiijjjk ll lllllmmmmnmnnnnnn oooooopqq qqº뮪벺뮔뙲hU hhU hwI5hhn5\ hh,whUhnhhn5hhn\hhn5CJ\hhn6B*]phhJ!6B*CJ]aJph hhnhhn5CJ\aJ6lmm`nnnoopp2r3rrrss~tuuaxcxxx$a$ Cx^x` x^x`x7$8$H$^x` x7$8$H$^xx7$8$H$^x`qq3rJrrrrrssss~ttttu vaxcxvxxxyy]z_zmz<{S{{{{||||K~Q~~~~$zҀӀhnCJ$OJQJ^J hU5\hUhhn5\$hhnCJOJPJQJ^JaJ*hhn5CJOJPJQJ\^JaJhhn\ hU5hnhhn5 hhnhhn;2xxyy^z`z;{<{{{||J~K~~~yzӀԀր׀ـ xx^x` x^x`ӀԀՀ׀؀ڀۀ݀ހ3TVǽӱױӞױӞמӱױh0JmHnHu h9]0Jjh9]0JU h9]CJh0JCJmHnHujh9]0JCJUh9]B*CJphh9]0JB*CJphh9]h9]0JCJhFQh3]hjhUhn5OJQJ\^J3ـڀ܀݀߀4UV H  !H$IjlƂȂɂʂ˂т҂ԂՂ%'VW]^`aÃ79GHkm&(HhD0JCJmHnHuh9]CJaJh$S60JCJmHnHu h9]aJh0JCJmHnHuh9]h9]0JCJ h9]CJjh9]0JCJUDJklǂȂɂʂ&'bƒ89l H$ !6$$ H  !H$Ʉ'HIAbc  @a H$  !H$h]h&`#$ H  !H$HIKLRSTU؅م߅67=>?@BbcƆ  1?`abpۇ   =>@`abhiklh|F0JCJmHnHuh9]0JCJaJh9]CJaJh9]0JCJmHnHuhD0JCJmHnHuh9]0JCJjh9]0JCJU h9]CJh9]Bab  ?`aVwxyz{>? H H$  !H$)*JKQRTUWwz{|=>?Nlûڬڐzll]lh9]6CJOJQJ^JaJh9]CJOJQJ^JaJ*h9]6B*CJEHOJQJ^JaJph'h9]B*CJEHOJQJ^JaJphjh9]Uj "? h9]CJUVaJjh9]UhhD0JCJmHnHu h9]CJh9]h|F0JCJmHnHuh9]0JCJjh9]0JCJU! !"hn5OJQJ\^Jhnh9]h9]CJOJQJ^JaJh9]5CJOJQJ^JaJ? !"9 0001P/ =!"#$% = 000&P1P/ =!"#$% 301P/ =!"#$% 6 00&PP/ =!"#$% 6 00&PP/ =!"#$% 6 00&PP/ =!"#$% 9 000&PP/ =!"#u$%] ,&P/ =!"#$% ,&P/ =!"#$% 9 000&PP/ =!"#r$% 6 00&PP!/ =!"#r$% / 01/ =!"#$% `!a4i+LyE=qYykx[ tս3ݙT0!| !|ZH` B y$YZţ5҃T[KKQW}(s'V=VjS|<;l&wpzN߽ٙ3w!!X<$h, ~dj]ui ΁nBMy] pT{kʪk> w5GFV?pUX̆.Ɗ';Q4x)Vu<hcSF_ p e{r9p?ZxUQnM1Nkn:'~ϴw<%S. fclZͩmֲdcM2KDUqd8w=PBz ͌Z˻Zt[{ܘnO&tJniJXkSw(~(}2pTJ<:^suiVG%Z 93J&<31l2g\̙C.'0c$n]* |ZֺVkJMkTQ:T`o z $Gks=^K{oA A10x3F` 耖s6*7ʬʺxm蜩Q~.xSDff~6TrRLVm^[*~,xOIi! G t/oNQZGG*(BKT MM~ 7R~+D{# +_D'_rS]f6fXu8; нE4[LT_Jt>͝CJ2XȂY/홥v0'>,vaY'? q;9U$?UTAvVGP\&(fV+} y{3غW-隨+ݺJl\LFG,Wc篙$£d~KH+_<$ustPe2۟']&Jt)`y[wf"yQf9B+~%i/ di%b5wYքR;RqQ:̄kmo`ޢ{D>g3Ggn2_E E"`&/I T,HPwYdq.F9RekbZkk5^^%<jYa0<Ь&54|n5c۽R2ʺdRp5>Vd%Sv( 7$I\M&"\˜5TZc3 ƛR2*Wk.~mNpg$ RM:d(}E";k`e85UDof۹Z{rI>ػӨl°bs݉/:c#jM;ރ*O]VHò,ʟ3 l2؜\raz9qWS蛌CKƍeںyk"xز ~g}ݮh+˾blIIcGms/{ ;Ic Z7&Si CG2>sc=[Ed&pO&Edݤ5BZ{2cfܬee ӹɭk%Zoj3 \m99°5}_m 5Eo_ϙ4d 4tstmb6g|Ley:Ӆ;c&WcLaQ}l~Y1RԐzϩh~Nߠqu`裄 ˓'\oO賗VF pcmCUWo-.kX kBʬxVCΔÙ*x??s굽X.Wy0"\ݢ4+jp+^Txvrm\NHpP@UݱjU2u=QӫOP0}*qaXJz0XI_%*kyqFR׋|BU'N_<, ,O0ޞDץ}|`kUA:Fஜ寳3>y4ZU30Exv!!}4}ʐ3$e|VʽLTj\`5߫{ڃCʋ!bӃ6J[+SW0l][2+R ,!9GٽZ= qa-9 ΁a5{'l/=QMdz"0,l JMѥ!e>jD+N mLlwa3jwp] &xYwas$2pIب73z<ػQkc mT9CW?0`(moF@OrH; nj_{ O]9=IBheb u0 #q^u} 9-ZI{:WzJzX32 T%jߪ3_LSn h_e֞60=Z6# p^jloN Mw);|oy}ތU*m`$;e7%KvST"JoA{ʛz>RΛ@Hf}x{CT SiߎiVUڑliND-Fch"*E.EP @D%N W_cȓؖd1x> -[WlNz1ޙ`WoE 3wi#G{M0 GՑ#˸|v5~ Qc~faZCcݦG.mӣ?G}.aZ9+Fv_ddmrZ»pٵֿErr?Z+mƵrշ R?]l#oN Dm2?e gưzTYi5[W}9ߋȫߙs&r*aUidhMįѮw[h$ Aᜨ`vq-#ƝfGbV@ՖKL-n)`Jݩ[[WUoU#gf }QW6^4riO>I; +ۯ@j7qVUId-E?*^喇ʸ1s)BЌ`:U.ΛI$x8F^"?_¹pV9UD>.t.I$#qFeؖ/6gOZ[;8;JF|)xɋyǟP=8}P۲@Pq<> evś&2^kr(S(+=0N\0pA8fx3ߠ Dd$ uXf  S 4AVistA Logo"`b$NӪiM-CWD nNӪiM-CWPNG  IHDR$LgAMA pHYs  IDATx_h[OW3Z\T7v  G"'PC B9CtJ՞wv E5 @/-h4FSm<RV&5~}InFKKYVχRȵ"*-͎\+ruKMt63]*ՒS7e:wdPRyraE)T>2٭ɅWL.XMCk]aql<ϊ HN/\ 2K{Dc|[ʈӽî>Ji-|P*_\)L$;4E_'0^6wu;tYշT#OR(ǯ/ixgˁ-A:-ʙVޓ\@ W^[;[)W{a7y _"2q1;m 4{4J5Ո1וRn/.(˧pS`X"֪%Ԡlw O` R'S@,WS5re-מ«Ch[ʈFb5d7w_a"٭j\sS->2s GoMBA+vEaW⠖>'VdjD/TU`oDv*2:O#uӔ–*@llNΔs59Jcct FUƲezKdA ć5Rʬ--'psuxlP.Ӌwe~&￸`(ݲ\iRY{;W|Pm PwmbSAY2^]$'vz(^/eYP*+kс` !oE ' vH5|4lNΨ^>cnscXUfDW&C(%8ͻ7TX>wdFn A̒~Pz+6Oژt?9uS`o%RCDZ._FB=D!%' |v@#X9/Bi7 7V.?UWfOk~n([-rߐٕ8{M//gK]0vfڷ5IןL{Jŧ.j;*j<vGF YR&ӽ~N0tk~Y (sQpt, L_3}aSND?0?O[ѩY5[d0j-[S7o,%i7iH%9uSn L$s&)}f9@lҙ>w47'gv ?D&&6k y._\X\X }X끎fJ#UpZOB3sf̀4<ۙ+q0;r^˫̧fUX9uˤn%nGRlW|"-UZ)=:eKԻ_ʬg6Z_)֍͹TyS,!J#l9Ab{4vGIbYXヲ'ًf,Xجx)M:nHx'dl0eeׯ*yv:1Q1)>.[RↂlN ҙŇ!? [Ҁ~BvivK:Ucg;4R93*zZ#-V9(3iy0IZ9+wi[ZJto Ŧo*_ӗhrHJs|.>qdj*l̲Wuᦀ%ujG;_i7uƾ,~ՙ"|>B7&RG*MYz?(_<_4ΗގHCŧ&G7/Fԙeׯ:*\&qA]{;8V9~?m>JĉVGH+3_"RmPlM*hS(fG.C_Azl8RA^|ͦ_,?b4j\Xأmd7lcC'BoRkDiMYtJo._+сH6ԢʈI|APwޅ/>whEOGHU2:'kՕJ4 ȵ26KJoI3}W2-4X+w3e??xVq E7 Ξm̢x3e{su׻*s?gfNBc/>n=?^o6-ѽ~QJ}}]fL!4 8YeuFfS&}]eD[́%2#'f2qH: 6J< -;\c'r"ncO8M)x$v$_ʵdA7 e?Jn]<8}UK{o[,'񟪳 yYavaX#'"-kSΫC!~)WʼS(3٭'rUM+E#!kGWPVᦀY|CC% ˣ6#Dpd{!lkY>%x+w:svGCxPcBf(ǧ,fJyF^mӝw-w 3q#ߘP)i9pmf$bgjXy(p! ~5 XUWG*YʬCi5A`ƼFZȞn`i5"Xlh8[sN`hrq&!fssPzʬ*j]q#>V  ."EtfC򍟗jXh_ $D`Sك"&]l-6n,~ lHWl`Dww4p:lx#8 6g7NQ_i$~ F^|ә4^?pzI#ĠxqCU܀Hx%x<܃#i8i$~* g&l܆7Hx8#6[g|]s4^?p-J#7>N gfYBdj~P+8&62IxV5,6xpLljZlA%xqLlq ^?Qj/jH-mA1yAMSKi$~P8)6CZI<@ 7p6d:; ^?ݺi$pAx lpi x'揶x'ŦUui$~UA,? `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.Ddh prV   c 2AKey 242:[9DQyD `![9DQyj dHGKx}wO9sw*"*aE%=²bAAtzjHED-h!/x~b_o3ܹs̙9d _6 ڙ[mȿ’ ˗/-oqf>K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\  # A"2 'L*dU?ī!@ s~ `! 'L*dU?ī!@(U_qtn xZ[L#>30\$'a׻nL#$lZV굇P{RQRԷH[HURmT}Z)RRRmէjDOHs7ꠙ9s\%"Ķ4JB;p"ϓo Ov a=-dxzN\; lzuu<71ax}-Z!295i!Q3dHP#1pz/+ ʟ ?C.y1Xg^@kW:x#a+v*޼[I0{ۈOŽ+p8(}{} o vxA+u}뾮G(ǁ1{ǻ k' nzUFTQvR#Qh 3HB$NƠ<=:iQ:>$斻w8*vT.ho}BA V2]\[ c0c ӈu8"cx1Ę"*,e ҖF_¤RP4jfAh B)&`أV7o [b:7I( -薮ݲQڢ9x49sez_-N!1]>-XmTܙ 8a;?̋ 'U4*:8(u; <8Yi0wϕie r#r+qdA/v!~֭uܔyTVn[m4Y=:LqP`~DpMIN(U m'Lgp1[op랒&oi@- 5ތgnU3嘒-jy825h;z`dj9iD8qTWhVPNq (Ya;;f03K }4WWxmV(zB:א%u 4W><03(lb|!OU0jQߧ;Td=J RhA1)-Vmbh #7͊͝ ɦ`G{o(qws?%̸]]uA*cR*wO7R+j bfOZ8zDynuP,3|&j6df<#cPыor6œX=Y X_j1oo\lr%p Y.*8n.6`><%%{tЌo'֖ wi+V5?OVQhQ/Eu-ƒJYuz@NT7z7f߷ K*y OL;E5-4Z vXR((x-2+Ί,-"uay1ǙfۚQ 34|t*rPm~3`^1Zs}Xӷ1!Q(힎̹]CZĻQ^!bƧYK'3P"DV3I=Y?*fxVuv@28M7iȞ~}$W3UC&FG:/޶LX+(DdH  s RAPencil 07Note icon"`2Pֆ鈪~H§>A,ш `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.(DdHll  s RA Pencil 07Note icon"`2Pֆ鈪~H§>A, `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.(DdHll  s RA Pencil 07Note icon"`2Pֆ鈪~H§>A,! `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytBy$$If!vh5555555#v#v:Vtl t655ytByDdh _cV  c 2A Key 242:[9DQy `![9DQyj dHGKx}wO9sw*"*aE%=²bAAtzjHED-h!/x~b_o3ܹs̙9d _6 ڙ[mȿ’ ˗/-oqf>K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\A,Q `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.Y$$If!vh55L52 55)#v#vL#v2 #v#v):V l44P 20&655L52 55)4f4p2$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l40&655L52 55)4f4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l_0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V lc0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V lo0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V lT0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4Y$$If!vh55L52 55)#v#vL#v2 #v#v):V l44P 20&655L52 55)4f4p2$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V ld0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V ld0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V ld0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V ld0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!vh55L52 55)#v#vL#v2 #v#v):V l0&655L52 55)4$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l          Z0$555v55v5*5~ 5 / 4pZkd?$$Ifl 8~ N :d$vvv*~           Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdnD$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdI$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdM$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdfR$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdW$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd[$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd^`$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkde$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdi$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdVn$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdr$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdw$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 / 4pZkdN|$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l          Z0$555v55v5*5~ 5 / 4pZkd$$Ifl 8~ N :d$vvv*~           Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdb$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd $$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdZ$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l          Z0$555v55v5*5~ 5 / 4pZkd$$Ifl 8~ N :d$vvv*~           Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd`$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdX$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdP$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdH$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l          Z0$555v55v5*5~ 5 / 4pZkd$$Ifl 8~ N :d$vvv*~           Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdN$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdF$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd>$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd6$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd $$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd.$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd~$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd&$$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd($$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdv-$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd2$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd6$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdn;$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd@$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdD$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdfI$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdN$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkdR$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd^W$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZ$$If!v h555v55v5v5*5~ 5 #v#v#vv#v#vv#v*#v~ #v :V l Z0$555v55v5*5~ 5 4pZkd\$$Ifl 8~ N :d$vvv*~  Z0$$$$$4 lapZDyK http://www.va.gov/vdl/yK .http://www.va.gov/vdl/(DdHll  s RA Pencil 07Note icon"` 2Pֆ鈪~H§>A,a `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.Ddh PM  s \A$Key 24Security Key Logo"`2:[9DQyf `![9DQyj dHGKx}wO9sw*"*aE%=²bAAtzjHED-h!/x~b_o3ܹs̙9d _6 ڙ[mȿ’ ˗/-oqf>K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\K~?bLާz"8ǫ'_)sjbrOyjJZlgJ4SeXdYe.8-3̣dM0iJgMo t:TYһ:,z_Q']E5n?P=J# }hާ/9MPiyEyqZGkxv1䚺:_sYϜOrV=azCm.9ω kNzs<B?2s9e.nnq:s?G|_yIDI3RK[9&QD[X'[";d$0Y'e|"+eLX+e̔iB$s$^#[aEZhk9rJߑZUhw`ZYk%٪$AF-#봔фK_SUJjr_fflo,*KQY%d_5fY,4$j:'餝|m@ʏZKYO-#z|wzK=hXCd䗯|TPfKa,]XQI7;| _tIiGN5ֹdOf5$ؾ%b]vףb٨V x!#aRqSApI-|o..(9|%˅ᗢxqx$((Uꈗ{&ӧԈԈ0 D?BR6 foื@y\8$R |E>Am7qI~'%/^»%8m  ~l~$ϛיg0ץ.&ܻ_ ~fٲ9c#GfnV;8N[C9FbxC|V`ϧ-%A LőԆRI4b Q#F&Oy3@x4:-4\h,hW S=KSFԍVS'G܈".rWM4 |b||Cr31dsFITNRQF(xnIK%=de */oSEH&KdTAާr;alW*$=(L׏B?=0+9"ѯ[Qx0#F}G_YZ|V]퇏#G.<]Zt"դ'%!\ 96z k[mѣ:DgԀ'QSC9>@ש;3L3ܛ}ͱP|4 u8ډ8\fq}"a,OPL<3P|D?5d<Ǜ>;2.5m Vsh~CKrIdrZ+iNdL\]øzȀ"O^z TNPIGt;uYQ  f2]3_)4N3֚4 fŘ $K_QbhUҍIg,SAҌzJC.uCQ()E](l7~.!F"KjCL."i[T!$?]"DZt*)*}`؍M롉kP,|T s4K9Z)hTR N}ОtUj Gw1qO 1ζTm1PJHjZ7-:4D֑X=/~Au|?u) ۨ~Cb]Kϣ"J~Khzc0R[ùژ;{V;r+ڇA\DrZOL0f.PBpF˹u>EWU^9u3*wRZ;9^0yīd-f!_3Y6׫`>*S[<,8] 'TkJpܫ/ ]o.K>|ݮ## aI칂ҋH4fB69| /-{PP$jgPC&2P'Л7M)yz[g:6ӉWA'npz)Mg4ġ_>٬TBv@碛dC?3 t4-. +dPPPRPREF.'іV2}:P\8Ƨ?@cWc_Hois͝3WEp\vu?3g֊8OѲ~hqмZm-on&:omj+[+i`I l %\ uBrJG0 !@Nw2lMf6te(j3J^v6\4\ppK%ﺔ̥I7gd Η c3w@?40科2$ (!+Zo"KֲPQ2.A}4\,pa.0 s7pq#yv. ᮁ[<$7xa5>WW93%:!$z+wx8m]c)ӻG{ Q`{[3>k9p/8 p%_ro0'f$ 5hwo|,&÷9aWuuqpiœqko..ifk_f joH\=mji+WMZB.t4K)SBR S=v\W=csj Slu]]k5]{:i\W-E\2EbO~ow~c#um;lcnVUPY2;maD?FڮɴQ~M1W#ZS'X)a % %2el-aJ]?Cz37GcOzIaJj{M=Ik&Mgln5-k~fn{3kb~ƽD9q'ўEܻ0WVinxmMI򺀞 aT7xHP `: Vu&2lYMfK+7z֫G?z}&U#h*?F5o;?&ҤG(dׁ97w?W1\\9yg]}˽\5WFw%5ѕChz`ADsqMOxw}-p`Ej]/%U8mvL?WD=1pf1#60-yMotmMgioMSԳCsMga-;&aڻ9i`'}ic.4 -WU^C_}an?]{ܷC{uKvLcm[b9fjF/8FnYx߬s}Lnv&{_^Ւ=6];6Ļ헅hC2Y7΂,lC,tiU uszlp<0 P}7I:8Wd(밯7S*K]*[ng NT9hpv\A,# `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.$$If!vh5<5L55X555#v<#vL#v#vX#v#v#v:V P4%5<5L55X555/ 44 Paf4Z$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4aZ$$If!vh5%#v%:V l%5%/ 4a$$If!vh5555555#v#v#v#v#v:V P4%55555/ 44 Pf4Z$$If0!vh5d%#vd%:V l%65d%/ 4Z$$If0!vh5d%#vd%:V l%65d%/ 4Z$$If0!vh5d%#vd%:V l%65d%/ 4Z$$If0!vh5d%#vd%:V l%65d%/ 4Z$$If0!vh5d%#vd%:V l%65d%/ 4Z$$If0!vh5d%#vd%:V l%65d%/ 4Z$$If0!vh5d%#vd%:V l%65d%/ 4Z$$If0!vh5d%#vd%:V l%65d%/ 4(DdHll   s RAPencil 07Note icon"` 2Pֆ鈪~H§>A, `!$ֆ鈪~H§>An dHG9xV}he?3"|Brd)l0^r]>^0v&dqfkq쨫^K@Ut٫/د!6&/#l\`& X>qA؉9|•x 7O%|"( !* ٬G<6qAsOX͎qfjTqUFBy6gYz7P4OV&zul㙨mbja݁-Ҷ`Nf >Bb/?R>.LbOFNpe&gQ9 LE6Wp";Ix![JO'.sf+nnYjr׼NuGi !yI(Vp>i{yLY$^L޸3~,T̓;*TjTP#"U֫bP_J_>2\vɹJ&AeC쑗op*Pa*1ڛ#o87K[D>%Zeܠ]o -m\%Xoi}=+{HS2My̎ U]xEYJ'|LBfP*?m:T~`$v'f)Ns#?j`!oP>,OJq\).ڀ23htK%E7,ʝM48c 6栞{cIOHkqhWyPsԻ**Is^ULź\{D/q8)bpr\Cz ?z pZ_6H{M;L&Ԛh6q*bZyj\ů3z+{ҍ.DyK http://www.va.gov/vdl/yK .http://www.va.gov/vdl/MDd@$1LL0  # A2a4i+LyE p`!a4i+LyE=qYykx[ tս3ݙT0!| !|ZH` B y$YZţ5҃T[KKQW}(s'V=VjS|<;l&wpzN  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoxI}~Root Entry F YzData WordDocument 72ObjectPooljY Y_1059195869 FjY mYOle F1Table|VOCompObjh  !"#$%&'()*+,-./0123456789:;<=>?@ABCDF6F\Drawing\~Page-1\Sheet.1  FMicrosoft Word Picture MSWordDocWord.Picture.89qOh+'0T 4@ ` l x  i8@8 NormalCJ_HaJmH sH tH <A@< Default Paragraph Font)Mr>dj6`j%4BFWel,<DSek     !$%&'()*+,/01234567:;<>@BDEFGHKLMQRS)Mr>dj6`j%4BFWel,<DSekn  !"#$%&'()*+,-./0123456789: @VT|}<=IJjk9:cdmn%&12@ANORScdqrxy !JKMNZ[jkrs000000000000000000000000000000000000000000000000000000000000 N lgh,2$H ..6, p@.,fg+(  <  # Rr  6Q r  6P r  6O <  # Nr  6M r   6L r   6K r   6J r   6I <   # Hr  6 G  <  # Fr  6 E  r  6 D  r  6 C  <  # Br  6 A  r  6@ r  6? <  # >r  6= r  6< r  6; <  # :x  <9 x  <8 x  <7 x  <6 x   < 5 x ! <!4 B " 3 3< # # 2x $ <$1 x % <%0 x & <&/ x ' <'. x ( <(- x ) <), x * <*+ x + < +*  x , <!,) !B - 3 (< . # 'x / <"/& "x 0 <#0% #x 1 <$1$ $x 2 <%2# %x 3 <&3" &x 4 <'4! 'x 5 <(5  (x 6 <)6 )x 7 <*7 *B 8 3 < 9 # x : <+: +x ; <,; ,x < <-< -< = # x > <.> .< ? # x @ </@ /< A # x B <0B 0< C # x D <1D 1x E <2E 2x F <3F 3x G <4G 4x H <5H  5B I 3  < J #  x K <6K  6x L <7L  7x M <8M 8@ +U6 TN N 3 4,6H O # +Um6H P # +U6G Q <9Q8-5 9 R <:RT,6 : S <;S020 ;B@ '\* WBB U  '5)6 V lBCDEFN @`)\*B@ '\* ZBB X  '=)> Y lBCDEFN @`)\*B@ '%\*% ]BB [  '\%)]% \ lBCDEFN @`)%\*%B@ '4\*4 `BB ^  '[4)\4 _ lBCDEFM @`)4\*4B@ ':\*;; cBB a  ':): b lBCDEFN @`):\*;;6B d  B@ $' gBB eB  R%D'E f lBCDEFP @`$W%B S  ?  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRg|LtdLlMtcL+c,t`L6%%t]L6tZL  tWLtT}!(tMM.-.tL,9!d-tK*E,tJ*!.tIl+""/tH-6.tGJ,!-tFg+o ,tES/0tD/0tC[/)1tBwtA,t@! t?8 t>Pt=t<<&(t;%(!&t:$0"%t9$!_(t8$w"(t7@'%(t69!&!w't52%"X&t4`BMt3"!xt2'"Yt19t0]O!t/"t.#ht-;$t,t+~"t*{#t)$[xt(<!t'$y"rt& w t%` E! t$*A t#-! t"m!d t! M t P !. tj  t+,t+~,ty*+t3*-t %_&t%~_&t#@%t#v&t g!tG t(t}!tht\trt,tt |6/t )  t  ` t E@ t @ t! t tctk<tKttTT}!=HYaOQdf:::::::::::::::;;ST@RF`@UnknownG:Times New Roman5Symbol3& :ArialMCentury Schoolbook"h jX&jX&!@>0dk2Kelly Anne CostelloEDSObjInfo ObjectPooljYjYWordDocument "SummaryInformation( M bjbj== "WWTll T ,T KGJGJGJ[K]K]K]K]K]K]K$L OVK GJ@ GJGJGJK[K,K[K[K[KGJ [K[KGJ[K[K[K[K\ [K #T > WJ[K[KK0K[KVOK@VO[K[K4 F  1. Use this option to review your drugs from the DRUG file (#50) and their matches to VA GENERIC file (#50.6). 2. Use this option to review your drugs from the DRUG file (#50) that are not presently matched to National Drug File (NDF). 3. Review steps number 1 and 2. 4. Use these two options to match as many entries from DRUG file (#50) to NDF. 5. Spot check PRIMARY DRUG file (#50.3). Check names to see if dose form, strength, or units are contained in the names. 6. Use this option to review. (optional) WARNING: This report is very long. 7. Use this option to review. (optional) WARNING: This report is very long. LOCAL DRUGS WITH NO MATCH TO NDF REPORT LOCAL DRUGS WITH NO MATCH TO NDF REPORT REMATCH/MATCH SINGLE DRUGS or AUTOMATIC MATCH OF UNMATCHED DRUGS REMATCH/MATCH SINGLE DRUGS or AUTOMATIC MATCH OF UNMATCHED DRUGS PRIMARY/VA GENERIC ORDERABLE ITEM REPORT PRIMARY/VA GENERIC ORDERABLE ITEM REPORT * * * * Options are located in the NDF package . VA GENERIC ORDERABLE ITEM REPORT VA GENERIC ORDERABLE ITEM REPORT NDF INFO FROM YOUR LOCAL DRUG FILE ST{};=HJik8:bdln$&02?AMOQSbdprwyB*OJQJph5B*OJQJ\phB*OJQJphjCJUmHnHuTT|}<=IJjkT9:cdmn%&12@ANNORScdqrxy!IKLNY[ikqs~5B*OJQJ\phB*OJQJphB*OJQJph$ !JKMNZ[jkrs 1hN N!@"@#$% Oh+'0p  , 8 DPX`hssKelly Anne Costelloellell Normal.dotCEDS2SMicrosoft Word 9.0@F#@ #@#DocumentSummaryInformation81TableSummaryInformation(DocumentSummaryInformation8  ՜.+,0 hp   Something  Title߽ٙ3w!!X<$h, ~dj]ui ΁nBMy] pT{kʪk> w5GFV?pUX̆.Ɗ';Q4x)Vu<hcSF_ p e{r9p?ZxUQnM1Nkn:'~ϴw<%S. fclZͩmֲdcM2KDUqd8w=PBz ͌Z˻Zt[{ܘnO&tJniJXkSw(~(}2pTJ<:^suiVG%Z 93J&<31l2g\̙C.'0c$n]* |ZֺVkJMkTQ:T`o z $Gks=^K{oA A10x3F` 耖s6*7ʬʺxm蜩Q~.xSDff~6TrRLVm^[*~,xOIi! G t/oNQZGG*(BKT MM~ 7R~+D{# +_D'_rS]f6fXu8; нE4[LT_Jt>͝CJ2XȂY/홥v0'>,vaY'? q;9U$?UTAvVGP\&(fV+} y{3غW-隨+ݺJl\LFG,Wc篙$£d~KH+_<$ustPe2۟']&Jt)`y[wf"yQf9B+~%i/ di%b5wYքR;RqQ:̄kmo`ޢ{D>g3Ggn2_E E"`&/I T,HPwYdq.F9RekbZkk5^^%<jYa0<Ь&54|n5c۽R2ʺdRp5>Vd%Sv( 7$I\M&"\˜5TZc3 ƛR2*Wk.~mNpg$ RM:d(}E";k`e85UDof۹Z{rI>ػӨl°bs݉/:c#jM;ރ*O]VHò,ʟ3 l2؜\raz9qWS蛌CKƍeںyk"xز ~g}ݮh+˾blIIcGms/{ ;Ic Z7&Si CG2>sc=[Ed&pO&Edݤ5BZ{2cfܬee ӹɭk%Zoj3 \m99°5}_m 5Eo_ϙ4d 4tstmb6g|Ley:Ӆ;c&WcLaQ}l~Y1RԐzϩh~Nߠqu`裄 ˓'\oO賗VF pcmCUWo-.kX kBʬxVCΔÙ*x??s굽X.Wy0"\ݢ4+jp+^Txvrm\NHpP@UݱjU2u=QӫOP0}*qaXJz0XI_%*kyqFR׋|BU'N_<, ,O0ޞDץ}|`kUA:Fஜ寳3>y4ZU30Exv!!}4}ʐ3$e|VʽLTj\`5߫{ڃCʋ!bӃ6J[+SW0l][2+R ,!9GٽZ= qa-9 ΁a5{'l/=QMdz"0,l JMѥ!e>jD+N mLlwa3jwp] &xYwas$2pIب73z<ػQkc mT9CW?0`(moF@OrH; nj_{ O]9=IBheb u0 #q^u} 9-ZI{:WzJzX32 T%jߪ3_LSn h_e֞60=Z6# p^jloN Mw);|oy}ތU*m`$;e7%KvST"JoA{ʛz>RΛ@Hf}x{CT SiߎiVUڑliND-Fch"*E.EP @D%N W_cȓؖd1x> -[WlNz1ޙ`WoE 3wi#G{M0 GՑ#˸|v5~ Qc~faZCcݦG.mӣ?G}.aZ9+Fv_ddmrZ»pٵֿErr?Z+mƵrշ R?]l#oN Dm2?e gưzTYi5[W}9ߋȫߙs&r*aUidhMįѮw[h$ Aᜨ`vq-#ƝfGbV@ՖKL-n)`Jݩ[[WUoU#gf }QW6^4riO>I; +ۯ@j7qVUId-E?*^喇ʸ1s)BЌ`:U.ΛI$x8F^"?_¹pV9UD>.t.I$#qFeؖ/6gOZ[;8;JF|)xɋyǟP=8}P۲@Pq<> evś&2^kr(S(+=0N\0pA8fx3ߠ 4 Note HeadingjDZ@D Plain TextkCJOJQJ^JaJ0K@0 Salutationl6@@6 Signature m^FJ@F Subtitlen$<@&a$ OJQJ^JT,T Table of Authoritieso^`L#L Table of Figuresp ^` V>@V Titleq$<@&a$5CJ KHOJQJ\^JaJ H.H  TOA Headingrx5OJQJ\^J`O2` }Manual-body texts p@ HCJOJPJ QJj@Cj FC Table Grid7:Vt0tJORJ Z TOC Heading u^CJ$OJQJ^JNObN wwI List Bullet2v & Fh1$^hCJ\\Oq\ vwIList Bullet2 Char CharCJ\_HmH sH tH "&;Wj%TzE";zW) a @AM\]stuvxyz{|}~[\ao|-.4>Hp/06@Jn  . 7    $ "cdjnrQC:x@@@ NormalCJ_HaJmH sH tH D@D Heading 1$@&CJ$OJQJ^JT@T Heading 2,head 2$@&5CJ$OJQJ\L@L Heading 3,head 3$@& 5CJ\:@: Heading 4$@&5\\@\ Heading 5$-D @&M 5CJOJQJ\^JH@H Heading 6 <@&5CJ\aJB@B Heading 7$@&`5\H@H Heading 8$8@&^8`5F @F Heading 9 $@&^ 5CJ\DA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k(No List 4@4 Header  !4 @4 Footer  !J@JTOC 1$@& 5CJOJQJaJ$mHnHuB@B TOC 2$@& 5CJOJQJ\]>@!> TOC 3 ^5CJOJQJ.@B. TOC 4 ^.. TOC 5 ^HaH TOC 6@& ^5CJ\aJBOrBStyle1 5;CJ$OJQJJOJStyle2^5;CJ$OJQJ.)@. Page NumberFOF Paragraph1$P1$a$CJaJHOH Table Text ((_HmH sH tH HOH RevHistory$$1$a$CJ$aJ.. TOC 7 ^.. TOC 8 ^.. TOC 9 ^6U@6 Hyperlink >*B*phDC@D Body Text Indent !`4Or4Style3 " & F\TR@2T Body Text Indent 2#,^,`\jS@Bj Body Text Indent 3$-D M ^CJOJQJ^JOR Section Headingk%$$ & F hd$d%d&d-D@& M NOPa$)@B*CJEHKHOJ QJ ^JaJph8P@b8 Body Text 2&5\FV`qF FollowedHyperlink >*B* phHOH heading1,head1(1$ 5^JaJ>0@> List Bullet ) & F aJB6@B List Bullet 2 * & F aJB7@B List Bullet 3 + & F aJB8@B List Bullet 4 , & FaJB9@B List Bullet 5 - & FaJ>1@> List Number . & FaJB:@B List Number 2 / & FaJB;@B List Number 3 0 & FaJB<@B List Number 4 1 & FaJB=@"B List Number 5 2 & FaJ> > Index 13^`aJ> > Index 24^`aJ> > Index 35^`aJ> > Index 46^`aJ>> Index 57^`aJ>> Index 68^`aJ>> Index 79^`aJ>> Index 8:^`aJ>> Index 9;p^p`aJ!2  Index HeadingT<$x$d %d &d 'd N O P Q a$5OJQJ\aJ>L@> Date= 8d1$7$8$H$ROR Manhd1>$ 87$8$H$a$5;CJ@OJQJPOP manhd3?$ 87$8$H$a$5CJ$OJQJJOJ ManRevD@$ 87$8$H$a$OJQJRYR  Document MapA-D M OJ QJ ^J <B@"< Body TextB5CJ\aJXO2X overviewC^`CJOJPJQJ^JaJJOBJ xl22Ddd[$\$CJOJPJQJ^JaJRORR Bullet1E & F^6<B* CJaJph:OQb: Bullet2F & Fh^h:OQr: Bullet3G`^``BOQB Bullet4H ^`8@8  Comment TextIaJ2OQ2 Bullet5 JP^PXOaX Heading 6 Bullet K & FCJOJQJ]aJ<Q@< Body Text 3L B*phF@F  Footnote TextM1$ CJaJhnOn Computer ScreenN-D 7$8$H$M 5CJOJQJ\^JaJHH  Balloon TextOCJOJ QJ ^J aJDT@D Block TextPx]^bM@!b Body Text First IndentQx`5CJ\aJ`N@"` Body Text First Indent 2Rhx^h`@"@ Caption Sxx5CJ\aJ2?@B2 Closing T^DjD Comment SubjectU 5CJ\<[@b< E-mail SignatureV<+r<  Endnote TextWCJaJh$@h Envelope Address!X@ &+D/^@ OJQJ^JN%@N Envelope ReturnYCJOJQJ^JaJ:`@: HTML AddressZ6]Re@R HTML Preformatted[CJOJQJ^JaJ4/@4 List\h^h`82@8 List 2]^`83@8 List 3^8^8`84@8 List 4_^`85@8 List 5`^`BD@B List Continueahx^hFE@"F List Continue 2bx^FF@2F List Continue 3c8x^8FG@BF List Continue 4dx^FH@RF List Continue 5ex^l-bl  Macro Text"f  ` @ OJQJ^J_HmH sH tH I@r Message Headergg8$d%d&d'd-DM NOPQ^8` OJQJ^J4^@4 Normal (Web)h>@> Normal Indent i^4O@<BFIE8#%&TUVWyz2367X  E r s %!&!~!!!!$"%"^"c""`###%%i%j%{%|%%%%%%y){)* ****++ +,+-+1+2+7++++++K,L,P,Q,Y,d-e-i-j-x------<.=.A.B.L..... /w/x/|/}//////0T0U0W0X0k00000011 1 1 1"1D2E2H2I2_2333333<5=5>5A5B5`5a5b5c5h5{5,7-7.7172737475767778797:7O799999:::::;;;<<h<k<l<o<q<<<==.>/>6>??"@#@@@NAOACC E"ELFNFPFWFGGGJJLLLqMrM}M~MMMMM NN)N*NQNRNNNNNNN2O3OqOrOOOOOOOOPPCPDPyPzPPPPPPPPPPQ5Q6QeQfQQQQQ RRRRRJR]R^RSSnϓ`ؔXw +=hÖޖP×ӗ9YϘ*;rי 0}5RsCל'Qx)jyО_5uƠ(T{ʡ+lҢ*TZФ2[ɥ_,Pw7Ψڨ aʩEWêЪm|3Z,mҭHXή.v 7P|԰^ɱʱ]DzEԳIJֵ$pǶʷBŸι:Ժ8y2zżCս!"#$QRST]^ž;־߾ )07?HQRZckt}ȿɿѿڿ )1:;DMV_gpyz!()08?HQY`ahov~  )2:CLMV^fnv~"+2:;DMV_hpyz %./8AHPX`hiqymnouv78Yxy*.@XYy/JKkxy;<Rop25HbcYZ[\])*MNtu 56no%&PQ-.vw#$JKpq')Kfg01]{|>?Oefv"#$<=>hi(459;=@PQRTY\pqrt}01234567;=EJUVWXYZ[\`bjoz{|~69OPQS[^klmo/2>?@ABCDEIKcf ,/MNOQ_b{|}-0IJKM]`36789:;<=>GIQT_`aclo1:;<>SVWXY[y|}~ #&;<=?LOPQRT^abcdfqtuvwxyz{| "#$&7:;<=?MPijkmz} CD|w=>cv  ;< +348:<?ABCSUVWY[^`abv{|}  6CDEGKNPQV /567:<?AFGUWXY\^bdijuyz{~ 3789;=@BCH\_`abcdefghijnpruwx}*+,.0356;FHIJLPSUVWi 134579<>?@NPQRTX[]^_l &./037:<=>Vnopswz|}~!"#&*-/01@TUVY\_abcx/12369<>?@IMNORVY[\]bstux{~%'(),/2456=OPQTWZ\]^gtuvy|!"#&(+-./GIJKLMNOPQRSTXZ^acdeKL ()ghqrCDxyz9:MN$%              @ A V v w x      0fuv~4\]^_&Ddv01jl  -Mj ,.-.~df !!!!""$$'''#'$'Y'''(_(a(((((())))C-E-G-----..... /&/B/\/^/?0A0]1^1h1j1111262R2n22233G4I4445555X7Z7d7e7999999:[:::;;I;d;;;;;;">>>>>????@ @>@@@AAAAAAkBBBBBBCCCCD.DJDfDDDDDEEEEEFF2G3G4GKGLGzG{G|GGGGGGGG,H-H.HCHDHIIIIIBJCJDJZJ[JJJJJJJJJ? #00>0>0000?0?000000000000000@0@0@00000000s000 0 0 0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdfghijklmnopqrstuvwxyz{|}~0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000u000000000000000000000000000000000000000000W0W0W0W0W0W0W 0W0W0W 0W0W0W 0W0W0W 0W0W0W0W0W0W0W0W 0W0W 0W#0W #0W#0W 0W0W 0W0W(00j%0j%0j%0j%0j%0%0%0%0%0%0%0%0%80%0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0*0* 0* 0* 0* 0* 0* 0* 0* 0*0* 0* 0* 0* 0* 0*0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0*0* 0* 0*0*0*0*0*0*0*0*0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0* 0*0j%0;0;0;0;0;0;0;0;0j%0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0j%0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0rM0j%0!W0!W0!W0!W80!W0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X&0 X0 X0 X0 X0 X0 X&0 X0 X0 X0 X0 X0 X&0 X0 X0 X0 X0 X0 X0 X0 X0 X0 X&0 X0 X0 X0 X0 X0 X0 X0 X80!W0f0f0f0f0f&0f0f0f0f0f0f&0f0f0f0f0f0f&0f0f0f0f0f0f80!W0fj0fj0fj0fj0fj0fj0fj0fj0fj0fj0fj&0fj0fj0fj0fj0fj0fj0fj&0fj0fj0fj0fj0fj0fj80!W0o0o0o0o0o0o&0o0o0o0o0o0o&0o0o0o0o0o0o&0o0o0o0o0o0o80!W0t0t0t0t0t0t0t&0t0t0t0t0t0t0t0t80!W04z04z04z04z04z&04z04z04z04z04z04z&04z04z04z04z04z04z&04z04z04z04z04z04z04z04z80!W0000000000000000000000000000000000000000000000000000080!W070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070707070780!W0505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505050505L0505050505050505050505050505050505N05N05050505050505N050505050505050505N05050505050505050505050505050505050505050j%0T0T0Tk0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T k0T k0T k0T k0T k0T k0T k0T 0T 0T0T0T0T0j%080800000800o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0oD0o0o0o0o0o0o0o0o0o0j%00800000800>0>0>0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> I0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0>0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0>0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0> 0>80000 0 0 0 0 0000000000000000000000000008080000000 0 0 M0 M0 0 0 0 0 0 0 M0 0 0 0 0 0 0 0 0 0 M0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 M0 M0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000000000000000000000000000j%0z0z0z0j%00000j%00000000j%0 0 0 0 0 0 0 0j%0 80 0 0 I0 B0 0 0 0 0 0 0 0 0 0 0 0 0 0j%0v0v0v0j%0000j%00000000000000000000000000000000j%080000800101010101010101010101010101010101010101010101010180000 00000000000 0000 0000000000000000000000000 00000000000000008 00000000000000080000 0000 00000&0&0080000000000000000 &00000000000000 &0000000000000000000000(000E000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000800000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 080000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0000000 000000000000000000000000000000000000C000000000000000000000000000@0H00@0H00@0H00@0H00@0H00V AN@0H0 0W BN@0@0@0@0H00SBN@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0H00880000000>@AM\]stuvxyz{|}~[\ao|-.4>Hp/06@Jn  . 7    $ "cdjnrQC:<BFIE8#%&TUVWyz2367X  E r s %!&!~!!!!$"%"^"c""`###%%i%j%{%|%%%%%%y){)* ****++ +,+-+1+2+7++++++K,L,P,Q,Y,d-e-i-j-x------<.=.A.B.L..... /w/x/|/}//////0T0U0W0X0k00000011 1 1 1"1D2E2H2I2_2333333<5=5>5A5B5`5a5b5c5h5{5,7-7.7172737475767778797:7O799999:::::;;;<<h<k<l<o<q<<<==.>/>6>??"@#@@@NAOACC E"ELFNFPFWFGGGJJLLLqMrM}M~MMMMM NN)N*NQNRNNNNNNN2O3OqOrOOOOOOOOPPCPDPyPzPPPPPPPPPPQ5Q6QeQfQQQQQ RRRRRJR]R^RSSnϓ`ؔXw +=hÖޖP×ӗ9YϘ*;rי 0}5RsCל'Qx)jyО_5uƠ(T{ʡ+lҢ*TZФ2[ɥ_,Pw7Ψڨ aʩEWêЪm|3Z,mҭHXή.v 7P|԰^ɱʱ]DzEԳIJֵ$pǶʷBŸι:Ժ8y2zżCս!"#$QRST]^ž;־߾ )07?HQRZckt}ȿɿѿڿ )1:;DMV_gpyz!()08?HQY`ahov~  )2:CLMV^fnv~"+2:;DMV_hpyz %./8AHPX`hiqymnouv78Yxy*.@XYy/JKkxy;<Rop25HbcYZ[\])*MNtu 56no%&PQ-.vw#$JKpq')Kfg01]{|>?Oefv"#$<=>hi(459;=@PQRTY\pqrt}01234567;=EJUVWXYZ[\`bjoz{|~69OPQS[^klmo/2>?@ABCDEIKcf ,/MNOQ_b{|}-0IJKM]`36789:;<=>GIQT_`aclo1:;<>SVWXY[y|}~ #&;<=?LOPQRT^abcdfqtuvwxyz{| "#$&7:;<=?MPijkmz} CD|w=>cv  ;< +348:<?ABCSUVWY[^`abv{|}  6CDEGKNPQV /567:<?AFGUWXY\^bdijuyz{~ 3789;=@BCH\_`abcdefghijnpruwx}*+,.0356;FHIJLPSUVWi 134579<>?@NPQRTX[]^_l &./037:<=>Vnopswz|}~!"#&*-/01@TUVY\_abcx/12369<>?@IMNORVY[\]bstux{~%'(),/2456=OPQTWZ\]^gtuvy|!"#&(+-./GIJKLMNOPQRSTXZ^acdeKL ()ghqrCDxyz9:%      @ A V v w x      0fuv~4\]^_&Ddv01jl  -Mj ,.-.~df !!!!""$$'''#'$'Y'''(_(a(((((())))C-E-G-----..... /&/B/\/^/?0A0]1^1h1j1111262R2n22233G4I4445555X7Z7d7e7999999:[:::;;I;d;;;;;;">>>>>????@ @>@@@AAAAAAkBBBBBBCCCCD.DJDfDDDDDEEEEEFF2G3G4GKGLGzG{G|GGGGGGGG,H-H.HCHDHIIIIIBJCJDJZJ[JJJJJJJJJ0>0000?0?000000000000000@0@0@00000000s000 0 0 0 0 J0(0n  J0(0l  0(0  J0(0j J0(0j  0(0 0(0 0(0 0(0 0(0 0(0 0(0 0(0 0(0 0(0 @00)0 0 0 0 0 00 0 0 0 0 00 0 0 0 0 00 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000u00r @0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0 @0@0@0@0@0@0@0@0@ 0@0@0@ 0@0@0@ 0@0@0@ 0@0@0@0@0@0@0@0@ 0@0@ 0@#0@ #0@#0@ 0@0@ 0@0 @(0@0"@0"@0"@0"@0"@0"@0"@0"@0"@0"@0"@0"@0":@0"@00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00(@00( @00( @00( @00( @00( @00( @00( @00( @00(@00( @00( @00( @00( @00( @00(@00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00(@00( @00( @00(@00(@00(@00(@00(@00(@00(@00(@00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00( @00(@0"@09@09@09@09@09@09@09@09@0"@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0:@0"@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0J@0@0"@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0O@0"@0nT@0nT@0nT@0nT:@0nT@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@&0XU@0XU@0XU@0XU@0XU@0XU@&0XU@0XU@0XU@0XU@0XU@0XU@&0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU@&0XU@0XU@0XU@0XU@0XU@0XU@0XU@0XU:@0nT@0c@0c@0c@0c@0c@&0c@0c@0c@0c@0c@0c@&0c@0c@0c@0c@0c@0c@&0c@0c@0c@0c@0c@0c:@0nT@0g@0g@0g@0g@0g@0g@0g@0g@0g@0g@0g@&0g@0g@0g@0g@0g@0g@0g@&0g@0g@0g@0g@0g@0g:@0nT@0l@0l@0l@0l@0      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHQJKLMNOPRSTUVWXYZ[\]^_`abcdefghijklnopqrstuvwxyz{|}~l@0l@&0l@0l@0l@0l@0l@0l@&0l@0l@0l@0l@0l@0l@&0l@0l@0l@0l@0l@0l:@0nT@0q@0q@0q@0q@0q@0q@0q@&0q@0q@0q@0q@0q@0q@0q@0q:@0nT@0w@0w@0w@0w@0w@&0w@0w@0w@0w@0w@0w@&0w@0w@0w@0w@0w@0w@&0w@0w@0w@0w@0w@0w@0w@0w:@0nT@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09@09:@0nT@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0:@0nT@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@L0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@N0@N0@0@0@0@0@0@0@N0@0@0@0@0@0@0@0@0@N0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0000@00000k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 k0 k0 k0 k0 k0 k0 k0 0 00@000:0:00000:000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@D0@0@0@0@0@0@0@0@0@0"@0@0:@0@0@0@0@0:@0@0p@0p@0p@0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @I0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p@0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p@0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p @0p:@0@0-@0-@0-@ 0-@ 0-@ 0-@ 0-@ 0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-@0-:@0:@0@0C@0C@0C@0C@0C@0C @0C @0C @M0C @M0C @0C @0C @0C @0C @0C @0C @M0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @M0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C@0C@0C @0C @0C @M0C @M0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @`Department of Veterans Affairs VistA Pharmacy Data Management Technical Manual / Security GuideDVistA Pharmacy Data Management Technical Manual / Security GuideDepartment of Veterans Affairs, Veterans Health Administration, Office of Information, Health Systems Design and DevelopmentVistA, Pharmacy, PDM Normal.dotvhaisboconng8Microsoft Office Word@2~@PyS@q@|U78?՜.+,D՜.+,| px  \Guide Department of Veterans Affairs n' `Department of Veterans Affairs VistA Pharmacy Data Management Technical Manual / Security Guide Title  8@ _PID_HLINKSA :xhttp://www.va.gov/vdl/ :xhttp://www.va.gov/vdl/ : _Toc193785032: _Toc193785031: _Toc193785030: _Toc193785029: _Toc193785028: _Toc193785027: _Toc193785026: _Toc193785025: _Toc193785024: _Toc193785023: _Toc193785022:z _Toc193785021:t _Toc193785020:n _Toc193785019:h _Toc193785018:b _Toc193785017:\ _Toc193785016:V _Toc193785015:P _Toc193785014:J _Toc193785013:D _Toc193785012:> _Toc193785011:8 _Toc193785010:2 _Toc193785009:, _Toc193785008:& _Toc193785007:  _Toc193785006: _Toc193785005: _Toc193785004: _Toc193785003: _Toc193785002: _Toc193785001  FMicrosoft Office Word Document MSWordDocWord.Document.89q0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C @0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0C@0"@0@0@0@0"@0'@0'@0'000000@0'@0"@0:@0@01@01@I01@B01@01@01@01@01@01@01@01@01@01@01@01@01@0"@0@0@0@0"@0/@0/@0/@0"@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0"@0k:@0k@0@0@0:@0k@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0:@0k@0@0@0@ 0@0@0@0@0@0@0@0@0@0@0@ 0@0@0@0@ 0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@ 0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0:@ 0@0@0@0@0@0@0@0@0@0@0@0@0@0@0:@0@0@0@0@ 0@0@0@0@ 0@0@0@0@0@&0@&0@0:@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@ &0@0@0@0@0@0@0@0@0@0@0@0@0@0@ &0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0 @(0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0:@0@0@0@0@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0:@0@0@0@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0@0@0@ 0@0@0@0@0@0@0@ 0@0@0 0000000000000000000000000000C000000000000000000000000 00B00=N@0@00000 @0@000 @0@000 @0@00 0 D:@0@00 0 <:@0@000\-:@000H]:@0@000]:@0@000:@000-:@0@0H00N@00000@+@0@0H0$0%N@00#00#0$@+@0@000@+@0@00)0*W@0@00)0*W@0@00/00y@0@00/00HX@0@005068yd@0J0>0?) 00H0ؼH0 %%%<<<Seeeuuu1199999888GG pYaK !!W""d#*5hDT[6_g}IfqtGMW^bagqӀH"  $)0ehjp    4 6 cQ8"'*{1-3K4d55<66w77T889D:;==a=-?9?BCqDKUCXZ]`dnrwe}`]۔D=5_$Q)Qc:My(8`o L^:My.Ahy8kuv45Y06U[zOk>D M{I7=_W} ;Pbu{";i3}:@Nnx@u!^ -)0A8X?CK4ORU`Yh]_MaaaLbbb!ccc-d}ddeDeeNflxـa?"    !"#%&'(*+,-./123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdfgiklmnoqrstuvwxyz{|}~  !"0LNOQq%_{}~!=@ACcx478:Z"h69:<\p <?@Bbx$@CDFf{'CFGIi|#?BCEe|2568Xg !#l___" X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%̕XX%,/<CE!w~  bik #v}!!t!!!t!!!!T!T!!!!!!:  A<?2$a4i+LyE $2$HaWR?k@t  ;(  xB  c HD$Decorative BorderxB   c HD$Decorative BorderxB  @ c HD$Decorative BorderxB  @ c HD$Decorative Borderj  &A ? Jæ@Creating and Matching Orderable Itemtx4: :,B4BA** 4 ] :" :Z**k: :::A*A*" b#:#:$ %:%:(!)4!)4.4/)5/A*21*23:k4:6 7]78*B9*|<4>]>SAA*/B4B4'E4)FA*G)5cI]cILL0:N)5:N)5OA*tQBRSODSS8Sy@SASADSAR:(R*tQBtQOPxOJNII*GIPCF&P>UO=*|<*B9%@8 7}75.6.6*6,4,84+3*2*21c321`T/`T|#Qb#*"*:**?BNEaNlM * *NaNlM4#" `H & # & `B '@ c 0D Arrow`B :@ c 0D ArrowH ; # ; B S  ?H0(  h<)"<t  $t h$ht Lh ht@d!+&%t't;p$Bt:pt3 OLE_LINK5 OLE_LINK6 _Hlk118610910 _Hlt193785256 OLE_LINK2 _Toc193785001 _Hlt83530275 _Toc193785002 _Hlt83530279 _Toc193785003 _Hlt83530269 _Toc396552202 _Toc193785004 _Toc396552203 _Toc193785005 _Toc193785006 _Hlt76200515 _Hlt83530282 _Toc193785007 _Toc193785008 OLE_LINK7 OLE_LINK8 _Toc193785009 _Toc193785010 _Toc193785011 _Toc193785012 OLE_LINK1 _Toc193785013 _Toc193785014 _Toc193785015 _Toc193785016 _Toc396552210 _Toc193785017 _Toc193785018 _Toc193785019 _Toc193785020 _Toc193785021 _Toc193785022 _Toc193785023 _Toc193785024 _Toc193785025 _Toc193785026 _Toc193785027 _Toc193785028 _Toc396552223 _Toc193785029 _Toc193785030 _Toc193785031 _Toc193785032 OLE_LINK3 OLE_LINK400'Wj%j%%%%;;<<sM"W"W"WTz  vEE4G|GG.HIDJJTVX{^_v}v}#@@@ @ @@ !"#$%&'()*+-,./012(cj%z%%%%<<==|M"W"W5W\8  EFJGGGBHIYJJVXX^_}}#" U"TW"W" U"$U"W"W"x"Tx"x"x"nx" ox"Lox"ox""t""t"<#t "p  "p  "Tp  "p  "|#t"dsvpvp33 UYUY\\a}a#      ppCCXYXY\\aa# :*urn:schemas-microsoft-com:office:smarttagsStreet;*urn:schemas-microsoft-com:office:smarttagsaddress9 *urn:schemas-microsoft-com:office:smarttagsState9*urn:schemas-microsoft-com:office:smarttagsplace H     ()/067>?Gaaxxxxxxxxxxxxz{#<< ()/067>?G-.0UWUoVVxxxxxxxxxxxxz{#333fm0O_~!Ax8h:p @x$D{'G|#C|6g!q<r<@@LL<=$%99VUWUyUzUVV]]sxxxxxxxxxxxxxxx5yTyyyyzKzjzzz{%{c{{{{|7|m||||(}G}}}}~~~B~a~b~b~~~~ A` @_Wvz{#xxxxxxxxxxxxz{#|R2}"W1~Jw0dr/-Mq,X+P* 3..F)E:}|\3(t%\3i16\3#\3f# zh FC8rKlGNoU\3nY̊"fa\3-ZerBz4 x\3z\3h~Vj^`.^`.88^8`.^`. ^`OJQJo( ^`OJQJo( 88^8`OJQJo( ^`OJQJo(hh^h`. hh^h`OJQJo(*h^`B*OJQJo(phh^`.hpLp^p`L.h@ @ ^@ `.h^`.hL^`L.h^`.h^`.hPLP^P`L.hh^h`CJOJQJo(hh^h`CJOJQJo(hh^h`CJOJQJo(hh^h`CJOJQJo(h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH ^`OJQJo(   ^ `OJQJo(o   ^ `OJQJo( xx^x`OJQJo( HH^H`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o ^`OJQJo(h^`B*OJQJo(phh dd^d`OJQJo(oh 44^4`OJQJo(h   ^ `OJQJo(h   ^ `OJQJo(oh ^`OJQJo(h tt^t`OJQJo(h DD^D`OJQJo(oh ^`OJQJo(hh^h`CJOJQJo(8^`o(.080^`0o(2.18 0 ^ `0o(2.8@ @ ^@ `.8^`.8L^`L.8^`.8^`.8PLP^P`L.hh^h`CJOJQJo(h^`.h^`.hpLp^p`L.h@ @ ^@ `.h^`.hL^`L.h^`.h^`.hPLP^P`L.hh^h`CJOJQJo(hh^h`CJOJQJo( X^`X56CJ$OJQJo(.08^`56CJOJQJo(9.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.nYh~i16oU4 x:}|z#(t%fa~}|-ZerlGlFCf#x @P^`PCJOJ QJ o(s                 ]                j% {               6wcJ        (nYxw\UDq FU\ f )C7xq~s 3eMw:T$!"*[,$S6;|<?8u?+AOnBFQUNSyVN'X/YZo\[(\ ]3]9]<]aL^bg'sh,i|ms+v-9wXxBye{e|}.n@ ,0W pcKAB6&L_:s,w=LbPsbU1D[b@K5T[zGn P(0PtEK]Nk~>wI#FC36"fQ|FqO5Ss5f5 J!U+~'9n-1M\ao|-.4>H/06@J  . 7    $ "cdjnr**++ +,+-+1+2+7++++++K,L,P,Q,Y,d-e-i-j-x------<.=.A.B.L..... /w/x/|/}//////0T0U0W0X0k00000011 1 1"1D2E2H2I2_233333=5>5A5B5`5a5b5c5h5{5-7.797:7O799999:::::;;ž;־߾ )07?HQRZckt}ȿɿѿڿ )1:;DMV_gpyz!()08?HQY`ahov~  )2:CLMV^fnv~"+2:;DMV_hpyz %./8AHPX`hiqyi(459;=@PQRTY\pqrt}01234567;=EJUVWXYZ[\`bjoz{|~69OPQS[^klmo/2>?@ABCDEIKcf ,/MNOQ_b{|}-0IJKM]`36789:;<=>GIQT_`aclo:;<>SVWXY[y|}~ #&;<=?LOPQRT^abcdfqtuvwxyz{| "#$&7:;<=?MPijkmz}>  +348:<?ABCSUVWY[^`abv{|}  6CDEGKNPQV /567:<?AFGUWXY\^bdijuyz{~ 3789;=@BCH\_`abcdefghijnpruwx}*+,.0356;FHIJLPSUVWi 134579<>?@NPQRTX[]^_l &./037:<=>Vnopswz|}~!"#&*-/01@TUVY\_abcx/12369<>?@IMNORVY[\]bstux{~%'(),/2456=OPQTWZ\]^gtuvy|!"#&(+-./GIJKLMNOPQRSTXZ^acde89bXXY)Y*Y9YDYJYMYRYYYaYbYYYYYYYYYZZZZLZMZNZOZZZZZZZZZZZZZ[ [!["[T[U[V[W[[[[[[[[[[[[[-\.\/\0\{\|\}\~\\\\\\\\\\\\]]]]B]C]D]E]v]w]x]y]]]]]xxxxxxzz|I}axyz#<@]]&]]"p@Unknowngz Times New RomanTimes New Roman5SymbolG& z ArialHelveticaQTimes New Roman Bold9 Webdings;Wingdings?5 : Courier NewU Arial Unicode MSArialA& {aMS Shell DlgC"MS Sans Serif?& Arial Black]& zaTahomaLucida Sans UnicodeG  MS Mincho-3 fg_R ZapfDingbatsMonotype Sorts#1h#<ȆB<ȆZf8? 8? !<4dnn NqHX ?}2_Department of Veterans Affairs VistA Pharmacy Data Management Technical Manual / Security Guide@VistA Pharmacy Data Management Technical Manual / Security GuideVistA, Pharmacy, PDM|Department of Veterans Affairs, Veterans Health Administration, Office of Information, Health Systems Design and Development vhaisboconngt                     CompObjEq